data_2lmc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lmc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD11 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' CG ' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.438 ' HB ' HG21 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.54 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.425 HD12 ' O ' ' B' ' 66' ' ' GLN . 20.3 mm . . . . . 0 C--O 1.236 0.359 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.457 ' HB2' ' O ' ' B' ' 53' ' ' GLY . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.482 HG23 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.612 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.425 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.7 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.412 HD12 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.451 ' HB2' HG13 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.591 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.591 ' H ' HG21 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.482 ' CZ ' HG23 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.632 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' B' ' 68' ' ' ASN . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.415 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' HD22 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 75' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' B' ' 66' ' ' GLN . 3.9 mm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.6 ' HB2' ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.535 HD12 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' THR . . . . . 0.418 ' O ' HG22 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.424 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.52 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.535 ' O ' HD12 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.593 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.4 ' HG2' HG21 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.471 ' CB ' HD11 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.547 ' ND2' HG22 ' B' ' 69' ' ' VAL . 6.9 p-10 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.547 HG22 ' ND2' ' B' ' 68' ' ' ASN . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.44 ' CZ ' HG22 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.484 HG12 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.484 ' H ' HG12 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 39' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 HD21 ' CG ' ' B' ' 45' ' ' ARG . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 4.0 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 41' ' ' GLU . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.482 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.462 HD12 ' O ' ' B' ' 55' ' ' ASP . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.432 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.53 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.462 ' O ' HD12 ' B' ' 30' ' ' ILE . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.451 ' HB3' HD23 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.499 ' HB2' ' CD2' ' B' ' 64' ' ' TRP . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.401 ' CD2' HD13 ' B' ' 61' ' ' ILE . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.589 HG23 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.589 ' H ' HG23 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 12.7 mptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 41' ' ' GLU . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.501 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.425 HD12 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' B' ' 43' ' ' LYS . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.423 HD21 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.431 HG21 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.425 ' O ' HD12 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.468 ' HB3' HG11 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.547 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.423 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.586 HG23 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.586 ' H ' HG23 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.459 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.501 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.417 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm . . . . . 0 C--O 1.235 0.295 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.453 HD11 ' O ' ' B' ' 55' ' ' ASP . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.472 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.416 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.453 ' O ' HD11 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.572 HG21 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.572 ' H ' HG21 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.472 ' H ' HG12 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--O 1.232 0.176 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.512 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.497 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.481 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 55' ' ' ASP . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.516 ' HG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' B' ' 74' ' ' ARG . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.469 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.481 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.516 HG23 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . 0.404 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' B' ' 66' ' ' GLN . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.562 HG23 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.562 ' H ' HG23 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.478 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD11 ' B' ' 33' ' ' ILE . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.516 ' HA ' ' HG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . 0.411 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.509 ' H ' HG11 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.436 ' HA ' HD21 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' B' ' 45' ' ' ARG . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 7.1 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG23 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.402 HD11 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.628 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.479 HD12 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.508 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 72' ' ' GLY . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.421 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.449 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.508 HG21 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.479 ' O ' HD12 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.458 HG21 ' O ' ' B' ' 44' ' ' ARG . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD11 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.586 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.586 ' H ' HG21 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.582 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.628 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.44 ' H ' HG11 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.473 ' HA ' ' CD2' ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.585 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.497 HD13 ' O ' ' B' ' 55' ' ' ASP . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.617 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.405 ' OG ' HG21 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.595 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.405 HG21 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.497 ' O ' HD13 ' B' ' 30' ' ' ILE . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.527 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.527 ' H ' HG21 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.617 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.471 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 CA--C 1.522 -0.115 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.696 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.518 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.513 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.47 HD13 ' O ' ' B' ' 55' ' ' ASP . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.696 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.521 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.47 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.496 ' HA ' HD21 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.424 ' HD2' ' CG1' ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.595 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.595 ' H ' HG21 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . 0.521 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.577 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.528 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 55' ' ' ASP . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.638 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.498 ' HD3' ' CG ' ' B' ' 36' ' ' PHE . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' SER . . . . . 0.59 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD12 ' B' ' 30' ' ' ILE . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' MET . . . . . 0.424 ' HE1' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' VAL . . . . . 0.57 HG23 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.57 ' H ' HG23 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.638 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ILE . . . . . 0.424 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.66 106.62 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t 62.75 -148.43 0.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.0 mt 62.94 93.7 0.05 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.253 0.549 . . . . 0.0 110.902 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 t -83.09 -76.27 0.28 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.54 178.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.43 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -124.99 40.97 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.525 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.684 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -63.28 -33.62 75.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 178.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.684 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -133.83 144.73 49.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD11 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' CG ' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.438 ' HB ' HG21 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.475 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.54 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t -120.0 88.45 2.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.45 -68.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.49 87.49 0.14 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 123.638 0.586 . . . . 0.0 111.126 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -39.99 128.33 2.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.021 3.147 . . . . 0.0 114.184 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.576 177.722 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.425 ' HG3' ' OE2' ' B' ' 29' ' ' GLU . 1.6 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.971 0.321 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.481 ' O ' HD11 ' B' ' 26' ' ' ILE . . . -146.93 -87.8 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.63 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.481 HD11 ' O ' ' B' ' 25' ' ' ALA . 20.3 mm -122.05 66.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.414 ' HG ' HD13 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.457 ' HB2' ' O ' ' B' ' 53' ' ' GLY . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.482 HG23 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.528 ' O ' HD11 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.612 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.425 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.7 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.412 HD12 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.451 ' HB2' HG13 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.591 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.591 ' H ' HG21 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.482 ' CZ ' HG23 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.632 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' B' ' 68' ' ' ASN . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.415 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.509 ' HA ' HD22 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.937 0.399 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.66 -53.33 4.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.046 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.5 m -58.83 -46.94 86.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.96 128.89 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.162 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 t -95.51 -142.93 0.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.392 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.11 173.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.017 0.437 . . . . 0.0 111.548 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -127.78 27.07 5.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.619 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -63.9 -24.97 67.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 111.292 178.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.619 ' N ' HD21 ' A' ' 33' ' ' ASN . 28.2 mmtp -121.79 163.72 18.65 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.105 174.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' HG3' HG23 ' A' ' 75' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.593 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.57 89.28 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 9.5 p -127.37 146.97 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.003 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.08 110.86 50.6 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.51 0.195 . . . . 0.0 111.424 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 81' ' ' VAL . 12.2 Cg_exo -70.96 99.65 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.909 2.406 . . . . 0.0 110.918 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.798 -174.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 -90.35 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.323 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' B' ' 66' ' ' GLN . 3.9 mm -121.44 80.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.6 ' HB2' ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.535 HD12 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.418 ' O ' HG22 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.424 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.52 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.535 ' O ' HD12 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.593 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.533 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.4 ' HG2' HG21 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.471 ' CB ' HD11 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.547 ' ND2' HG22 ' B' ' 69' ' ' VAL . 6.9 p-10 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.547 HG22 ' ND2' ' B' ' 68' ' ' ASN . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.44 ' CZ ' HG22 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.484 HG12 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.484 ' H ' HG12 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 121.039 0.447 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 66' ' ' GLN . . . 175.46 101.46 0.15 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.4 m -152.28 178.51 9.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.4 mt -128.4 178.96 5.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.695 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 31' ' ' VAL . 50.9 m -150.13 123.51 9.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 30' ' ' SER . 4.5 m 60.51 -41.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 167.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t0 61.19 75.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.696 0.68 . . . . 0.0 110.777 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -120.13 -27.67 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.208 173.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.681 ' N ' HD21 ' A' ' 33' ' ' ASN . 30.7 mmtp -117.73 170.88 8.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.199 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 39' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 HD21 ' CG ' ' B' ' 45' ' ' ARG . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.49 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 4.0 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 41' ' ' GLU . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m -92.25 91.88 7.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.83 -25.86 29.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 83.38 20.89 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.146 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.67 156.46 65.94 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.302 . . . . 0.0 112.856 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.1 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 4.6 Cg_exo . . . . . 0 CA--C 1.517 -0.352 0 N-CA-C 110.671 -0.549 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.83 -145.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.054 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.45 80.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.482 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.462 HD12 ' O ' ' B' ' 55' ' ' ASP . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.432 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.53 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.462 ' O ' HD12 ' B' ' 30' ' ' ILE . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.451 ' HB3' HD23 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.499 ' HB2' ' CD2' ' B' ' 64' ' ' TRP . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . 0.499 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.401 ' CD2' HD13 ' B' ' 61' ' ' ILE . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.589 HG23 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.589 ' H ' HG23 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD23 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.482 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.878 0.371 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.43 49.74 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.59 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.451 ' C ' HD21 ' A' ' 29' ' ' LEU . 12.6 p -145.02 -85.79 0.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.871 0.367 . . . . 0.0 110.576 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 ' C ' ' A' ' 28' ' ' SER . 3.1 mm? -133.73 -179.19 5.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.647 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t -179.83 -155.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.69 167.0 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.347 . . . . 0.0 110.128 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.68 17.48 8.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.658 0.266 . . . . 0.0 110.812 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.644 ' ND2' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -42.24 -59.01 1.95 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.7 mptt -100.79 141.62 33.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.994 -0.441 . . . . 0.0 110.284 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 41' ' ' GLU . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.08 86.92 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.23 -83.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.713 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -104.56 -50.69 0.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.338 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 13.9 Cg_endo -57.78 133.52 56.73 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 121.956 1.771 . . . . 0.0 112.242 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.113 -178.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 1.2 Cg_endo . . . . . 0 N--CA 1.474 0.38 0 N-CA-C 110.792 -0.503 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 82' ' ' SER . . . -96.82 -154.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.741 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm -72.08 83.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.501 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.425 HD12 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' B' ' 43' ' ' LYS . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.423 HD21 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.431 HG21 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.425 ' O ' HD12 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.468 ' HB3' HG11 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.547 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.423 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.586 HG23 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.586 ' H ' HG23 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.459 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.501 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' B' ' 25' ' ' ALA . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.16 -112.75 0.43 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.824 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.8 m -84.25 -20.86 31.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.277 0.561 . . . . 0.0 109.851 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.78 104.63 6.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.093 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 t -71.01 -70.78 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.794 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 33' ' ' ASN . 7.1 p -154.02 135.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.525 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 9.5 p-10 -92.52 29.24 1.77 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.339 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -54.55 -47.23 73.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.925 177.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 71.5 mmtt -97.07 167.02 11.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 32' ' ' ASP . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.417 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t -108.12 111.91 24.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.34 106.95 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.55 117.99 66.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.309 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.55 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.991 2.46 . . . . 0.0 112.749 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.416 ' C ' ' HZ2' ' A' ' 34' ' ' LYS . 12.9 tmtt? . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.562 ' HA ' ' OXT' ' B' ' 84' ' ' GLY . 2.2 Cg_endo . . . . . 0 N--CA 1.473 0.295 0 N-CA-C 110.858 -0.478 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.04 -146.37 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.6 76.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.453 HD11 ' O ' ' B' ' 55' ' ' ASP . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.472 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.439 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.416 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.453 ' O ' HD11 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' MET . . . . . . . . . . . . . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.572 HG21 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.572 ' H ' HG21 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.472 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.472 ' H ' HG12 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.562 ' OXT' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.37 128.1 1.46 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.765 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p -102.75 -179.51 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.937 0.398 . . . . 0.0 110.725 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.81 116.47 31.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 6.8 m -85.9 -168.67 2.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.281 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.06 150.22 11.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 6.3 p-10 -123.39 47.84 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.591 -174.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.655 ' ND2' ' HG2' ' A' ' 34' ' ' LYS . 1.3 p-10 -75.57 -35.43 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 33.1 mmtp -98.78 167.34 10.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' O ' ' HB2' ' A' ' 30' ' ' SER . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.512 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.497 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.481 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p -66.78 89.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 p -79.08 77.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.164 0.983 . . . . 0.0 111.445 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.92 74.7 80.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.462 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.65 88.47 1.42 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.067 2.511 . . . . 0.0 112.289 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.583 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.477 0.532 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.426 ' H ' ' CD2' ' B' ' 27' ' ' LEU . . . -113.4 -130.38 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.949 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm -84.2 77.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 55' ' ' ASP . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.516 ' HG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' B' ' 74' ' ' ARG . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.469 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.481 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.516 HG23 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . 0.404 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' B' ' 66' ' ' GLN . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.562 HG23 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.562 ' H ' HG23 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.478 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD11 ' B' ' 33' ' ' ILE . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.516 ' HA ' ' HG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.411 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.509 ' H ' HG11 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.436 ' HA ' HD21 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.618 0.247 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.77 55.15 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -154.44 -80.64 0.09 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.693 0.282 . . . . 0.0 111.275 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.5 tp -166.74 129.28 1.81 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.9 p -109.59 -63.27 1.38 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 33' ' ' ASN . 10.5 p -156.89 131.59 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.832 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.08 20.84 14.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.985 0.421 . . . . 0.0 111.067 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -50.85 -46.95 60.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.501 178.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 32.8 mmtp -97.19 164.24 12.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' B' ' 45' ' ' ARG . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 7.1 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG23 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.52 109.51 21.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.49 128.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.446 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.62 87.48 56.36 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -67.15 -43.65 6.07 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.756 2.304 . . . . 0.0 111.617 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.536 179.738 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.44 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.638 -0.562 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.75 -92.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.402 HD11 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm -115.46 77.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.628 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.479 HD12 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.508 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 72' ' ' GLY . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.421 ' NZ ' HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.449 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.508 HG21 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.479 ' O ' HD12 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.458 HG21 ' O ' ' B' ' 44' ' ' ARG . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD11 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.586 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.586 ' H ' HG21 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.582 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.628 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.44 ' H ' HG11 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.473 ' HA ' ' CD2' ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.977 0.417 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.72 0.33 89.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.911 -0.662 . . . . 0.0 114.005 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -148.92 -85.12 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.752 0.776 . . . . 0.0 111.941 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -107.12 112.35 25.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.104 0.478 . . . . 0.0 111.786 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -102.26 -62.13 1.3 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -160.09 142.48 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.43 32.86 2.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.879 0.371 . . . . 0.0 111.973 -173.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.683 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -72.17 -26.72 62.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.731 0.777 . . . . 0.0 110.082 174.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.683 ' N ' HD21 ' A' ' 33' ' ' ASN . 69.8 mmtt -122.21 169.85 10.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.322 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.585 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p -81.35 89.37 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -93.19 152.79 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 112.96 5.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 O-C-N 123.162 0.289 . . . . 0.0 111.007 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.75 60.69 7.78 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.785 2.323 . . . . 0.0 111.665 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 C--O 1.246 0.889 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.759 -177.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.478 0.61 0 N-CA-C 110.549 -0.596 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 -143.18 0.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.326 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm -74.2 81.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.497 HD13 ' O ' ' B' ' 55' ' ' ASP . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.617 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.405 ' OG ' HG21 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.595 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.405 HG21 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.497 ' O ' HD13 ' B' ' 30' ' ' ILE . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.527 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.527 ' H ' HG21 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.447 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.617 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.471 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.736 0.303 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.459 ' HA2' HD22 ' A' ' 62' ' ' LEU . . . 160.43 44.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.642 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -114.06 174.57 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.369 0.604 . . . . 0.0 111.604 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 52' ' ' TYR . 10.2 mp -85.43 101.11 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.669 176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -64.06 -63.01 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.568 -175.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.13 -38.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.787 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 t70 64.18 74.55 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.388 0.613 . . . . 0.0 111.086 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.603 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -95.74 -29.75 14.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.468 175.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' N ' HD21 ' A' ' 33' ' ' ASN . 4.6 mptp? -106.04 -174.84 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.416 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HA ' ' OG ' ' A' ' 30' ' ' SER . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.696 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD22 ' HA2' ' A' ' 27' ' ' GLY . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.518 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m -116.28 90.75 3.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.33 -28.36 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.232 0.539 . . . . 0.0 109.979 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.93 85.56 59.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.662 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.25 119.03 6.01 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.977 2.452 . . . . 0.0 112.32 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.725 179.055 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 110.338 -0.678 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.4 -91.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.068 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.78 99.98 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.513 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.47 HD13 ' O ' ' B' ' 55' ' ' ASP . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.696 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.521 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.47 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.496 ' HA ' HD21 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.424 ' HD2' ' CG1' ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.595 HG21 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.595 ' H ' HG21 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.521 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.577 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 11.4 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.95 0.405 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.88 57.53 5.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.896 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -104.7 168.99 8.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.793 0.33 . . . . 0.0 110.591 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 HD22 ' CE2' ' A' ' 52' ' ' TYR . 50.1 mt -84.82 -168.5 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.008 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -173.97 -163.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.72 140.68 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.67 35.29 3.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.695 HD21 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.74 -27.48 68.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.12 0.486 . . . . 0.0 111.755 -178.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.695 ' N ' HD21 ' A' ' 33' ' ' ASN . 9.6 mmpt? -121.8 -179.47 4.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.424 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CE2' HD22 ' A' ' 29' ' ' LEU . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 26' ' ' THR . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m -81.1 89.14 5.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.73 -44.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.273 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 74.87 79.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.64 -1.7 11.09 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.747 2.298 . . . . 0.0 113.414 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.072 -179.356 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' B' ' 82' ' ' SER . . . -130.02 -141.49 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 mm -79.77 75.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.528 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.411 HD12 ' O ' ' B' ' 55' ' ' ASP . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.638 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LYS . . . . . 0.671 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.498 ' HD3' ' CG ' ' B' ' 36' ' ' PHE . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' SER . . . . . 0.59 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD12 ' B' ' 30' ' ' ILE . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.424 ' HE1' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' TRP . . . . . 0.418 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . 0.57 HG23 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.57 ' H ' HG23 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.638 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLU . . . . . 0.444 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ILE . . . . . 0.424 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.405 ' O ' ' HB1' ' B' ' 25' ' ' ALA . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 40' ' ' VAL . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG23 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.476 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.445 ' CG2' ' H ' ' B' ' 60' ' ' MET . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' B' ' 66' ' ' GLN . 20.3 mm . . . . . 0 C--O 1.236 0.359 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' CG ' HH21 ' B' ' 44' ' ' ARG . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' B' ' 50' ' ' PRO . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.578 ' HB3' HD12 ' B' ' 30' ' ' ILE . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.445 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HG3' HD12 ' B' ' 26' ' ' ILE . 8.9 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.474 ' HB2' HG11 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.677 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.677 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.637 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.514 HG12 HG12 ' B' ' 81' ' ' ILE . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.514 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 58' ' ' GLU . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.481 ' H ' HG23 ' A' ' 39' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' B' ' 66' ' ' GLN . 3.9 mm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.623 HD12 ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.512 HD13 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.632 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' THR . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.523 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.632 HG22 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.512 ' O ' HD13 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.44 ' HB3' HD22 ' A' ' 60' ' ' LEU . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.603 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.516 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.623 ' HA2' HD12 ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.601 HG13 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.601 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.507 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.475 ' H ' HG22 ' A' ' 55' ' ' THR . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' B' ' 58' ' ' GLU . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' OE2' ' HD3' ' B' ' 38' ' ' LYS . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 6.7 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.556 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 78' ' ' ARG . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 23.1 mm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.402 HG11 HD21 ' B' ' 68' ' ' ASN . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.537 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.442 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.469 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.567 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.412 ' HB3' HG21 ' A' ' 77' ' ' VAL . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' TRP . . . . . 0.521 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.401 ' HG3' HG21 ' B' ' 26' ' ' ILE . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.465 ' HB2' HG11 ' B' ' 80' ' ' VAL . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.727 ' H ' HG22 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.466 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.502 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.502 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 12.7 mptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 75' ' ' THR . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' B' ' 58' ' ' GLU . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.501 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' THR . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.693 HG12 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' B' ' 43' ' ' LYS . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.55 HD22 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.416 HG12 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.6 HG22 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.422 ' O ' HD13 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.693 ' HB3' HG12 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' B' ' 26' ' ' ILE . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.715 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.715 ' H ' HG22 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 63' ' ' ALA . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.403 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.554 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 58' ' ' GLU . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 51' ' ' ILE . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' HE2' ' B' ' 43' ' ' LYS . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG21 ' H ' ' B' ' 60' ' ' MET . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' B' ' 66' ' ' GLN . 9.5 mm . . . . . 0 C--O 1.235 0.295 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.492 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' B' ' 50' ' ' PRO . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD2' ' CD1' ' B' ' 67' ' ' LEU . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HB3' HD12 ' B' ' 30' ' ' ILE . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.415 HG22 ' HA2' ' B' ' 32' ' ' GLY . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.436 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 60' ' ' LEU . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.462 ' H ' HG21 ' A' ' 77' ' ' VAL . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' B' ' 26' ' ' ILE . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' B' ' 44' ' ' ARG . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.708 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.708 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 74' ' ' ARG . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.55 HG13 ' H ' ' B' ' 81' ' ' ILE . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.55 ' H ' HG13 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.452 ' HA ' HD23 ' B' ' 27' ' ' LEU . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--O 1.232 0.176 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 74' ' ' VAL . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 63' ' ' ALA . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' H ' ' B' ' 58' ' ' GLU . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 40' ' ' VAL . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.579 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' B' ' 66' ' ' GLN . 22.2 mm . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' B' ' 50' ' ' PRO . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.406 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' THR . . . . . 0.474 HG21 HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.521 ' O ' HG22 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' B' ' 59' ' ' GLU . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' B' ' 58' ' ' GLU . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.556 ' HB3' HD12 ' B' ' 30' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.463 HG22 ' HA2' ' B' ' 32' ' ' GLY . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLU . . . . . 0.499 ' HG2' HD23 ' B' ' 46' ' ' LEU . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.579 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.459 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.713 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.713 ' H ' HG22 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.53 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.61 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.61 ' H ' HG13 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.545 ' HA ' HD23 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' B' ' 58' ' ' GLU . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.7 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HG3' HG21 ' B' ' 40' ' ' THR . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG21 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG21 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.639 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.404 HD13 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.589 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.458 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.472 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.667 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' B' ' 62' ' ' PRO . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' TRP . . . . . 0.402 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.623 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.623 ' H ' HG22 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.589 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.443 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.639 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.518 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.575 ' HA ' HD23 ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.578 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 56' ' ' LEU . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 36' ' ' PHE . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' B' ' 50' ' ' PRO . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.707 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.413 ' OG ' HG23 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.612 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.413 HG23 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.707 HG22 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.457 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' TRP . . . . . 0.416 ' CE2' ' HB3' ' B' ' 62' ' ' PRO . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.644 ' H ' HG22 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.627 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.44 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 CA--C 1.522 -0.115 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.429 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' HE2' ' A' ' 67' ' ' TYR . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' B' ' 43' ' ' LYS . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG11 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' B' ' 50' ' ' PRO . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.409 ' C ' ' HB3' ' B' ' 45' ' ' ARG . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.705 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.505 ' H ' HG11 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HD2' HG13 ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 61' ' ' ILE . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.716 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.716 ' H ' HG22 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.533 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' B' ' 58' ' ' GLU . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.46 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' B' ' 66' ' ' GLN . 17.8 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 74' ' ' ARG . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.661 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.418 ' HG ' HG13 ' B' ' 61' ' ' ILE . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 60' ' ' LEU . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' B' ' 46' ' ' LEU . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLN . . . . . 0.43 ' HB3' HD12 ' B' ' 26' ' ' ILE . 52.5 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.411 ' HB2' HG11 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.729 ' H ' HG22 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.646 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ILE . . . . . 0.516 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.66 106.62 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t 62.75 -148.43 0.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.0 mt 62.94 93.7 0.05 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.253 0.549 . . . . 0.0 110.902 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 t -83.09 -76.27 0.28 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.54 178.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.43 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -124.99 40.97 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.525 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.771 HD22 ' HA ' ' A' ' 54' ' ' GLU . 6.7 p30 -63.28 -33.62 75.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -133.83 144.73 49.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.771 ' HA ' HD22 ' A' ' 33' ' ' ASN . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 40' ' ' VAL . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG23 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.476 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.445 ' CG2' ' H ' ' B' ' 60' ' ' MET . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t -120.0 88.45 2.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.45 -68.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.49 87.49 0.14 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 123.638 0.586 . . . . 0.0 111.126 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -39.99 128.33 2.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.021 3.147 . . . . 0.0 114.184 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.576 177.722 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' B' ' 27' ' ' LEU . 1.6 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.971 0.321 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.496 ' O ' HD13 ' B' ' 26' ' ' ILE . . . -146.93 -87.8 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.63 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' B' ' 66' ' ' GLN . 20.3 mm -122.05 66.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' CG ' HH21 ' B' ' 44' ' ' ARG . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' B' ' 50' ' ' PRO . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.578 ' HB3' HD12 ' B' ' 30' ' ' ILE . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.445 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HG3' HD12 ' B' ' 26' ' ' ILE . 8.9 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.474 ' HB2' HG11 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.677 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.677 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.637 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.514 HG12 HG12 ' B' ' 81' ' ' ILE . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.514 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.937 0.399 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.66 -53.33 4.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.046 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.5 m -58.83 -46.94 86.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.96 128.89 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.162 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 t -95.51 -142.93 0.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.392 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.11 173.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.017 0.437 . . . . 0.0 111.548 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -127.78 27.07 5.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -63.9 -24.97 67.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 111.292 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -121.79 163.72 18.65 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.105 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 58' ' ' GLU . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.481 ' H ' HG23 ' A' ' 39' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.57 89.28 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 9.5 p -127.37 146.97 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.003 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.08 110.86 50.6 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.51 0.195 . . . . 0.0 111.424 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 81' ' ' VAL . 12.2 Cg_exo -70.96 99.65 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.909 2.406 . . . . 0.0 110.918 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.798 -174.731 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 -90.35 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.323 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' B' ' 66' ' ' GLN . 3.9 mm -121.44 80.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.623 HD12 ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.512 HD13 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.632 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.523 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.632 HG22 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.512 ' O ' HD13 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.44 ' HB3' HD22 ' A' ' 60' ' ' LEU . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.603 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.516 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.623 ' HA2' HD12 ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.601 HG13 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.601 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 121.039 0.447 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 66' ' ' GLN . . . 175.46 101.46 0.15 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.4 m -152.28 178.51 9.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 52' ' ' TYR . 43.4 mt -128.4 178.96 5.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.695 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' VAL . 50.9 m -150.13 123.51 9.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' SER . 4.5 m 60.51 -41.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 167.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t0 61.19 75.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.696 0.68 . . . . 0.0 110.777 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -120.13 -27.67 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.208 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -117.73 170.88 8.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.199 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.507 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' H ' HD22 ' A' ' 29' ' ' LEU . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.475 ' H ' HG22 ' A' ' 55' ' ' THR . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' B' ' 58' ' ' GLU . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' OE2' ' HD3' ' B' ' 38' ' ' LYS . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 6.7 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.556 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 78' ' ' ARG . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m -92.25 91.88 7.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.83 -25.86 29.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 83.38 20.89 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.146 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.67 156.46 65.94 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.302 . . . . 0.0 112.856 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.1 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 4.6 Cg_exo . . . . . 0 CA--C 1.517 -0.352 0 N-CA-C 110.671 -0.549 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.83 -145.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.054 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 23.1 mm -77.45 80.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.402 HG11 HD21 ' B' ' 68' ' ' ASN . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.537 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.442 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.469 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.567 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.412 ' HB3' HG21 ' A' ' 77' ' ' VAL . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' TRP . . . . . 0.521 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.401 ' HG3' HG21 ' B' ' 26' ' ' ILE . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.465 ' HB2' HG11 ' B' ' 80' ' ' VAL . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.727 ' H ' HG22 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.466 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.502 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.502 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.878 0.371 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.43 49.74 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.59 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' HD22 ' A' ' 29' ' ' LEU . 12.6 p -145.02 -85.79 0.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.871 0.367 . . . . 0.0 110.576 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 28' ' ' SER . 3.1 mm? -133.73 -179.19 5.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.647 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t -179.83 -155.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.69 167.0 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.347 . . . . 0.0 110.128 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.68 17.48 8.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.658 0.266 . . . . 0.0 110.812 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -42.24 -59.01 1.95 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 12.7 mptt -100.79 141.62 33.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.994 -0.441 . . . . 0.0 110.284 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 75' ' ' THR . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' B' ' 58' ' ' GLU . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.501 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' THR . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.693 HG12 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.08 86.92 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.23 -83.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.713 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.704 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -104.56 -50.69 0.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.338 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 13.9 Cg_endo -57.78 133.52 56.73 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 121.956 1.771 . . . . 0.0 112.242 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.113 -178.915 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 1.2 Cg_endo . . . . . 0 N--CA 1.474 0.38 0 N-CA-C 110.792 -0.503 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 82' ' ' SER . . . -96.82 -154.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.741 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm -72.08 83.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' B' ' 43' ' ' LYS . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.55 HD22 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.416 HG12 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.6 HG22 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.422 ' O ' HD13 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.693 ' HB3' HG12 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' B' ' 26' ' ' ILE . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.715 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.715 ' H ' HG22 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' B' ' 25' ' ' ALA . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.16 -112.75 0.43 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.824 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.8 m -84.25 -20.86 31.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.277 0.561 . . . . 0.0 109.851 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.78 104.63 6.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.093 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 t -71.01 -70.78 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.794 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 33' ' ' ASN . 7.1 p -154.02 135.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 9.5 p-10 -92.52 29.24 1.77 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.339 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' H ' HG22 ' A' ' 31' ' ' VAL . 29.3 p-10 -54.55 -47.23 73.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.925 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HZ3' ' C ' ' A' ' 84' ' ' LYS . 71.5 mmtt -97.07 167.02 11.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 63' ' ' ALA . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 32' ' ' ASP . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.554 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 58' ' ' GLU . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 51' ' ' ILE . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' HE2' ' B' ' 43' ' ' LYS . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG21 ' H ' ' B' ' 60' ' ' MET . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t -108.12 111.91 24.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.34 106.95 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.55 117.99 66.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.309 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.55 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.991 2.46 . . . . 0.0 112.749 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' C ' ' HZ3' ' A' ' 34' ' ' LYS . 12.9 tmtt? . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.574 ' HA ' ' OXT' ' B' ' 84' ' ' GLY . 2.2 Cg_endo . . . . . 0 N--CA 1.473 0.295 0 N-CA-C 110.858 -0.478 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.04 -146.37 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' B' ' 66' ' ' GLN . 9.5 mm -78.6 76.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.492 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' B' ' 50' ' ' PRO . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD2' ' CD1' ' B' ' 67' ' ' LEU . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HB3' HD12 ' B' ' 30' ' ' ILE . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.415 HG22 ' HA2' ' B' ' 32' ' ' GLY . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.436 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 60' ' ' LEU . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.462 ' H ' HG21 ' A' ' 77' ' ' VAL . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' B' ' 26' ' ' ILE . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' B' ' 44' ' ' ARG . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.708 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.708 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 74' ' ' ARG . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.55 HG13 ' H ' ' B' ' 81' ' ' ILE . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.55 ' H ' HG13 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.452 ' HA ' HD23 ' B' ' 27' ' ' LEU . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.574 ' OXT' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.37 128.1 1.46 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.765 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p -102.75 -179.51 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.937 0.398 . . . . 0.0 110.725 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.81 116.47 31.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 6.8 m -85.9 -168.67 2.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.281 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.06 150.22 11.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 6.3 p-10 -123.39 47.84 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.591 -174.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' ND2' ' HG2' ' A' ' 34' ' ' LYS . 1.3 p-10 -75.57 -35.43 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 33.1 mmtp -98.78 167.34 10.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 74' ' ' VAL . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 63' ' ' ALA . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' SER . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' H ' ' B' ' 58' ' ' GLU . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 40' ' ' VAL . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.579 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p -66.78 89.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 p -79.08 77.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.164 0.983 . . . . 0.0 111.445 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.92 74.7 80.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.462 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.65 88.47 1.42 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.067 2.511 . . . . 0.0 112.289 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.583 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.477 0.532 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.464 ' H ' ' CD2' ' B' ' 27' ' ' LEU . . . -113.4 -130.38 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.949 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' B' ' 66' ' ' GLN . 22.2 mm -84.2 77.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' B' ' 50' ' ' PRO . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.406 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.474 HG21 HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.521 ' O ' HG22 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' B' ' 59' ' ' GLU . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' B' ' 58' ' ' GLU . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.556 ' HB3' HD12 ' B' ' 30' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.463 HG22 ' HA2' ' B' ' 32' ' ' GLY . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.499 ' HG2' HD23 ' B' ' 46' ' ' LEU . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.579 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.459 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.713 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.713 ' H ' HG22 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.53 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.61 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.61 ' H ' HG13 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.545 ' HA ' HD23 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.618 0.247 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.77 55.15 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -154.44 -80.64 0.09 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.693 0.282 . . . . 0.0 111.275 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.5 tp -166.74 129.28 1.81 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.9 p -109.59 -63.27 1.38 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 33' ' ' ASN . 10.5 p -156.89 131.59 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.832 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.08 20.84 14.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.985 0.421 . . . . 0.0 111.067 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.527 ' H ' HG22 ' A' ' 31' ' ' VAL . 29.0 p-10 -50.85 -46.95 60.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.501 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -97.19 164.24 12.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' VAL . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' B' ' 58' ' ' GLU . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 47.7 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HG3' HG21 ' B' ' 40' ' ' THR . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG21 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG21 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.52 109.51 21.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 56' ' ' LEU . 22.1 t -71.49 128.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.446 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.62 87.48 56.36 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -67.15 -43.65 6.07 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.756 2.304 . . . . 0.0 111.617 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.536 179.738 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.508 ' HA ' HD21 ' B' ' 27' ' ' LEU . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.638 -0.562 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.75 -92.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm -115.46 77.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.639 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.404 HD13 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.589 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.458 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.472 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.667 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' B' ' 62' ' ' PRO . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' TRP . . . . . 0.402 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.623 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.623 ' H ' HG22 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.589 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.443 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.639 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.518 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.575 ' HA ' HD23 ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.977 0.417 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.72 0.33 89.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.911 -0.662 . . . . 0.0 114.005 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -148.92 -85.12 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.752 0.776 . . . . 0.0 111.941 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -107.12 112.35 25.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.104 0.478 . . . . 0.0 111.786 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -102.26 -62.13 1.3 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -160.09 142.48 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.43 32.86 2.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.879 0.371 . . . . 0.0 111.973 -173.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -72.17 -26.72 62.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.731 0.777 . . . . 0.0 110.082 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -122.21 169.85 10.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.322 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.578 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 56' ' ' LEU . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 36' ' ' PHE . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p -81.35 89.37 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -93.19 152.79 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 112.96 5.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 O-C-N 123.162 0.289 . . . . 0.0 111.007 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.75 60.69 7.78 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.785 2.323 . . . . 0.0 111.665 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 C--O 1.246 0.889 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.759 -177.503 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.478 0.61 0 N-CA-C 110.549 -0.596 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 -143.18 0.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.326 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm -74.2 81.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' B' ' 50' ' ' PRO . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.707 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.413 ' OG ' HG23 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.612 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.413 HG23 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.707 HG22 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.457 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' TRP . . . . . 0.416 ' CE2' ' HB3' ' B' ' 62' ' ' PRO . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.644 ' H ' HG22 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.627 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.44 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.736 0.303 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 62' ' ' LEU . . . 160.43 44.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.642 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -114.06 174.57 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.369 0.604 . . . . 0.0 111.604 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 52' ' ' TYR . 10.2 mp -85.43 101.11 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.669 176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -64.06 -63.01 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.568 -175.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.13 -38.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.787 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 t70 64.18 74.55 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.388 0.613 . . . . 0.0 111.086 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -95.74 -29.75 14.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.468 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -106.04 -174.84 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' HE2' ' A' ' 67' ' ' TYR . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.443 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 30' ' ' SER . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 27' ' ' GLY . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' B' ' 43' ' ' LYS . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG11 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m -116.28 90.75 3.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.33 -28.36 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.232 0.539 . . . . 0.0 109.979 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.93 85.56 59.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.662 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.25 119.03 6.01 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.977 2.452 . . . . 0.0 112.32 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.725 179.055 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 110.338 -0.678 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.4 -91.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.068 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.78 99.98 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' B' ' 50' ' ' PRO . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.409 ' C ' ' HB3' ' B' ' 45' ' ' ARG . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.705 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.505 ' H ' HG11 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HD2' HG13 ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 61' ' ' ILE . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.716 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.716 ' H ' HG22 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.533 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 11.4 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.95 0.405 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 66' ' ' GLN . . . -84.88 57.53 5.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.896 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -104.7 168.99 8.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.793 0.33 . . . . 0.0 110.591 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 52' ' ' TYR . 50.1 mt -84.82 -168.5 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.008 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -173.97 -163.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 33' ' ' ASN . 12.5 p -60.72 140.68 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.67 35.29 3.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.622 HD22 ' HA ' ' A' ' 54' ' ' GLU . 11.2 p30 -61.74 -27.48 68.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.12 0.486 . . . . 0.0 111.755 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -121.8 -179.47 4.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.424 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 29' ' ' LEU . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.622 ' HA ' HD22 ' A' ' 33' ' ' ASN . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' B' ' 58' ' ' GLU . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' THR . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.46 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m -81.1 89.14 5.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.73 -44.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.273 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 74.87 79.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.64 -1.7 11.09 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.747 2.298 . . . . 0.0 113.414 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.072 -179.356 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 -141.49 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' B' ' 66' ' ' GLN . 17.8 mm -79.77 75.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 74' ' ' ARG . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.661 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.418 ' HG ' HG13 ' B' ' 61' ' ' ILE . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 60' ' ' LEU . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' B' ' 46' ' ' LEU . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.43 ' HB3' HD12 ' B' ' 26' ' ' ILE . 52.5 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.411 ' HB2' HG11 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.729 ' H ' HG22 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.646 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ILE . . . . . 0.516 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 40' ' ' VAL . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG23 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.476 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.445 ' CG2' ' H ' ' B' ' 60' ' ' MET . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' B' ' 66' ' ' GLN . 20.3 mm . . . . . 0 C--O 1.236 0.359 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' CG ' HH21 ' B' ' 44' ' ' ARG . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' B' ' 50' ' ' PRO . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.578 ' HB3' HD12 ' B' ' 30' ' ' ILE . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.445 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HG3' HD12 ' B' ' 26' ' ' ILE . 2.7 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.474 ' HB2' HG11 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.677 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.677 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.637 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.514 HG12 HG12 ' B' ' 81' ' ' ILE . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.514 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 58' ' ' GLU . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.481 ' H ' HG23 ' A' ' 39' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' B' ' 66' ' ' GLN . 3.9 mm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.623 HD12 ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.512 HD13 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.632 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.523 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.632 HG22 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.512 ' O ' HD13 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.44 ' HB3' HD22 ' A' ' 60' ' ' LEU . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.603 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' B' ' 69' ' ' VAL . 6.9 p-10 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.539 HG22 ' ND2' ' B' ' 68' ' ' ASN . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.516 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.623 ' HA2' HD12 ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.601 HG13 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.601 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.507 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.475 ' H ' HG22 ' A' ' 55' ' ' THR . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' B' ' 58' ' ' GLU . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' OE2' ' HD3' ' B' ' 38' ' ' LYS . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 4.0 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.556 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 78' ' ' ARG . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 23.1 mm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.402 HG11 HD21 ' B' ' 68' ' ' ASN . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.537 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.442 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.469 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.567 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.412 ' HB3' HG21 ' A' ' 77' ' ' VAL . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . 0.521 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.401 ' HG3' HG21 ' B' ' 26' ' ' ILE . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.465 ' HB2' HG11 ' B' ' 80' ' ' VAL . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.727 ' H ' HG22 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.466 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.502 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.502 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 12.7 mptt . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.865 0.364 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 75' ' ' THR . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' B' ' 58' ' ' GLU . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.501 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' THR . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.693 HG12 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.521 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' B' ' 43' ' ' LYS . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.55 HD22 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.416 HG12 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.6 HG22 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.422 ' O ' HD13 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.693 ' HB3' HG12 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' B' ' 26' ' ' ILE . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.715 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.715 ' H ' HG22 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 63' ' ' ALA . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.403 ' N ' ' HD1' ' A' ' 52' ' ' TYR . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.554 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 58' ' ' GLU . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 51' ' ' ILE . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' HE2' ' B' ' 43' ' ' LYS . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG21 ' H ' ' B' ' 60' ' ' MET . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' B' ' 66' ' ' GLN . 9.5 mm . . . . . 0 C--O 1.235 0.295 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.492 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' B' ' 50' ' ' PRO . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD2' ' CD1' ' B' ' 67' ' ' LEU . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HB3' HD12 ' B' ' 30' ' ' ILE . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.415 HG22 ' HA2' ' B' ' 32' ' ' GLY . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.436 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 60' ' ' LEU . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.462 ' H ' HG21 ' A' ' 77' ' ' VAL . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' B' ' 26' ' ' ILE . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' B' ' 44' ' ' ARG . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.708 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.708 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 74' ' ' ARG . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.55 HG13 ' H ' ' B' ' 81' ' ' ILE . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.55 ' H ' HG13 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.452 ' HA ' HD23 ' B' ' 27' ' ' LEU . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--O 1.232 0.176 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 74' ' ' VAL . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 63' ' ' ALA . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' H ' ' B' ' 58' ' ' GLU . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 40' ' ' VAL . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.579 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' B' ' 66' ' ' GLN . 22.2 mm . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' B' ' 50' ' ' PRO . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.406 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . 0.474 HG21 HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.521 ' O ' HG22 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' B' ' 59' ' ' GLU . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' B' ' 58' ' ' GLU . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.556 ' HB3' HD12 ' B' ' 30' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.463 HG22 ' HA2' ' B' ' 32' ' ' GLY . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . 0.499 ' HG2' HD23 ' B' ' 46' ' ' LEU . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.579 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.459 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.713 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.713 ' H ' HG22 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.53 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.61 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.61 ' H ' HG13 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.545 ' HA ' HD23 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' B' ' 58' ' ' GLU . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 7.1 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HG3' HG21 ' B' ' 40' ' ' THR . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG21 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG21 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.639 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.404 HD13 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.589 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.458 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.472 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.667 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' B' ' 62' ' ' PRO . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . 0.402 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.623 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.623 ' H ' HG22 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.589 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.443 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.639 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.518 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.575 ' HA ' HD23 ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.578 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 56' ' ' LEU . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 36' ' ' PHE . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' B' ' 50' ' ' PRO . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.707 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.413 ' OG ' HG23 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.612 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.413 HG23 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.707 HG22 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.457 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . 0.416 ' CE2' ' HB3' ' B' ' 62' ' ' PRO . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.644 ' H ' HG22 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.627 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.44 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? . . . . . 0 CA--C 1.522 -0.115 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.429 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' HE2' ' A' ' 67' ' ' TYR . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' B' ' 43' ' ' LYS . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG11 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.524 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' B' ' 50' ' ' PRO . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.409 ' C ' ' HB3' ' B' ' 45' ' ' ARG . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.705 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.505 ' H ' HG11 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HD2' HG13 ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 61' ' ' ILE . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.716 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.716 ' H ' HG22 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.533 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' B' ' 58' ' ' GLU . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.46 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' B' ' 66' ' ' GLN . 17.8 mm . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 74' ' ' ARG . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.661 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.418 ' HG ' HG13 ' B' ' 61' ' ' ILE . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 60' ' ' LEU . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' B' ' 46' ' ' LEU . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.43 ' HB3' HD12 ' B' ' 26' ' ' ILE . 7.7 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.411 ' HB2' HG11 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.729 ' H ' HG22 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.646 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ILE . . . . . 0.516 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.66 106.62 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t 62.75 -148.43 0.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.0 mt 62.94 93.7 0.05 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.253 0.549 . . . . 0.0 110.902 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 t -83.09 -76.27 0.28 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.654 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.54 178.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.43 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -124.99 40.97 3.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.525 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.732 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -63.28 -33.62 75.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.331 178.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -133.83 144.73 49.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 174.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 16.9 pttm -96.54 122.48 39.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 111.115 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 23.8 m-85 -115.07 136.04 53.55 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -105.7 133.8 49.85 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.25 116.92 15.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.753 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.7 t -90.5 126.53 35.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.67 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.7 OUTLIER -115.4 149.59 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.237 -173.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.58 135.04 49.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.039 0.447 . . . . 0.0 110.362 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -103.07 -162.94 0.95 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.038 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -61.09 -31.23 70.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.933 0.397 . . . . 0.0 111.015 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.06 -45.02 0.52 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.055 0.455 . . . . 0.0 110.63 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -71.61 155.57 40.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.39 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -146.81 129.17 15.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.5 174.73 11.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.921 0.391 . . . . 0.0 111.559 -174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 36.0 mt-10 -121.85 137.7 54.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.801 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 8.6 p -140.31 135.03 15.77 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.143 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 13.1 Cg_exo -70.64 147.1 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.436 2.09 . . . . 0.0 112.415 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 20.7 mm -104.62 135.8 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -115.61 111.42 20.62 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.211 0.529 . . . . 0.0 110.811 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.15 174.92 13.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.985 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.78 -51.21 5.98 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 2.1 m -100.67 155.67 17.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' O ' ' B' ' 58' ' ' GLU . 2.7 mm? -56.17 -64.24 0.92 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.592 0.234 . . . . 0.0 111.247 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 32.7 t70 -51.63 -38.1 53.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 54.6 tt0 -57.24 -47.84 80.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.634 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -68.08 -38.4 82.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.547 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' B' ' 45' ' ' ARG . 17.5 tp -57.07 -42.84 81.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.855 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 49.3 mt-10 -59.97 -53.74 54.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.989 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 75.2 mt -64.03 -42.9 96.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.316 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.32 -46.32 46.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.196 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 38.9 tt0 -82.27 -61.41 1.9 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.122 0.487 . . . . 0.0 110.76 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -27.12 69.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.81 -167.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.8 tp60 -84.48 -32.44 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.322 . . . . 0.0 111.577 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -92.16 -33.27 14.79 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.45 -33.33 8.72 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.12 -10.95 21.23 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.321 1.507 . . . . 0.0 111.966 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.57 2.43 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.81 3.0 77.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.488 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 40' ' ' VAL . 96.8 m-85 -95.7 127.87 42.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -102.25 117.1 34.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG23 ' HE2' ' B' ' 43' ' ' LYS . 34.4 m -62.3 143.16 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.335 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -105.09 -48.48 3.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.944 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.476 ' HG3' ' CG ' ' B' ' 62' ' ' PRO . 9.8 ttp180 -165.75 154.97 11.96 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.445 ' CG2' ' H ' ' B' ' 60' ' ' MET . 5.0 m -130.52 157.35 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.648 177.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -145.53 102.93 4.28 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.094 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' B' ' 59' ' ' GLU . 27.1 Cg_exo -65.19 133.24 34.55 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.697 2.265 . . . . 0.0 111.422 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 46.4 t -120.0 88.45 2.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.45 -68.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.49 87.49 0.14 Allowed Pre-proline 0 N--CA 1.463 0.204 0 O-C-N 123.638 0.586 . . . . 0.0 111.126 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -39.99 128.33 2.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.021 3.147 . . . . 0.0 114.184 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.576 177.722 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' B' ' 27' ' ' LEU . 1.6 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.971 0.321 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.496 ' O ' HD13 ' B' ' 26' ' ' ILE . . . -146.93 -87.8 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.63 177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.565 HD12 ' HG3' ' B' ' 66' ' ' GLN . 20.3 mm -122.05 66.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' B' ' 83' ' ' ASP . 4.3 pp -150.23 174.48 12.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.388 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.51 123.32 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.213 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 7.8 tp10 -61.57 -24.42 66.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.226 0.536 . . . . 0.0 110.15 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' B' ' 50' ' ' PRO . 18.9 pt -133.89 153.34 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.863 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.637 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 8.3 t -83.4 138.46 33.48 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 158.21 -156.91 27.83 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.06 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mm -97.29 107.26 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.681 0.276 . . . . 0.0 110.293 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.2 p -82.08 128.32 38.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 14.4 p -130.69 163.64 26.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.5 m-85 -113.7 155.32 25.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.125 0.488 . . . . 0.0 110.95 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -138.75 -162.21 9.06 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.274 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.463 ' HZ3' ' CD ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.21 141.0 30.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.622 0.725 . . . . 0.0 112.367 -172.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' CG ' HH21 ' B' ' 44' ' ' ARG . 0.0 OUTLIER -130.18 116.69 18.79 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.774 173.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 13.3 t -58.81 -30.26 67.48 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.94 -81.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.779 0.323 . . . . 0.0 110.935 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.19 46.23 1.05 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 9.6 mptt -113.38 -163.6 0.87 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.424 -175.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 0.3 OUTLIER -158.7 121.09 3.61 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 39.5 ttt180 -77.68 111.19 13.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.052 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.47 ' HG ' HD12 ' B' ' 61' ' ' ILE . 4.0 mm? -92.74 102.57 14.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 110.648 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.73 104.01 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.308 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -93.29 133.15 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.339 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' B' ' 50' ' ' PRO . 86.3 m -98.73 96.64 4.07 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.13 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.578 ' HB3' HD12 ' B' ' 30' ' ' ILE . 18.4 Cg_endo -61.29 134.61 53.05 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.079 2.52 . . . . 0.0 113.85 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 34.2 m -113.24 -13.34 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.202 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 4.4 t70 -80.34 -20.4 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.921 -176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 169.33 171.42 34.98 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.7 p -80.66 63.06 4.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.168 0.509 . . . . 0.0 110.697 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -125.06 93.25 46.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.965 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 137.19 55.27 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.862 2.375 . . . . 0.0 112.63 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -145.5 109.98 5.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.158 0.504 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 56' ' ' LEU . 11.3 mp0 -132.13 142.16 49.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.804 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' PRO . 14.8 pt-20 -154.63 174.11 15.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.208 0.527 . . . . 0.0 111.029 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.445 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 ttp -112.87 92.38 3.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.354 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.482 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 24.7 mt -95.48 123.5 56.25 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.476 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 48.3 Cg_exo -57.78 153.12 45.27 Favored 'Trans proline' 0 CA--C 1.526 0.112 0 C-N-CA 122.847 2.365 . . . . 0.0 112.677 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.4 OUTLIER -72.8 -17.71 61.54 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.631 -174.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -18.1 55.0 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.514 0.673 . . . . 0.0 109.815 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -75.02 135.12 41.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.565 ' HG3' HD12 ' B' ' 26' ' ' ILE . 2.7 pt20 -67.7 106.47 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' B' ' 36' ' ' PHE . 17.0 mt -78.07 165.55 23.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.303 -171.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.474 ' HB2' HG11 ' B' ' 80' ' ' VAL . 23.9 p-10 -63.27 -49.52 73.74 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.677 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.6 p -169.29 -176.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.677 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.4 m-85 -76.87 179.09 6.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.375 0.534 . . . . 0.0 111.394 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.5 pt-20 -80.15 147.17 31.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.12 79.25 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.54 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -103.8 142.64 34.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.029 0.443 . . . . 0.0 111.314 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 10.0 tpt180 -88.81 123.29 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.921 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.44 169.78 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.593 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.637 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.3 tt0 -115.05 157.69 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.296 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.6 ttm-85 -54.82 113.84 1.49 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.636 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.8 -34.24 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.48 106.99 18.88 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.682 -0.304 . . . . 0.0 110.777 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.514 HG12 HG12 ' B' ' 81' ' ' ILE . 14.3 t -154.02 -79.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.748 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.514 HG12 HG12 ' B' ' 80' ' ' VAL . 39.8 mm -120.33 -50.24 3.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.188 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 28.9 t -146.84 125.16 12.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.447 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' B' ' 27' ' ' LEU . 6.0 p-10 -89.97 144.58 25.8 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.476 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.844 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.417 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.937 0.399 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.66 -53.33 4.82 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.278 -0.487 . . . . 0.0 113.046 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.5 m -58.83 -46.94 86.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.96 128.89 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.162 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 t -95.51 -142.93 0.26 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.392 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.11 173.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.017 0.437 . . . . 0.0 111.548 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -127.78 27.07 5.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.665 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -63.9 -24.97 67.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 111.292 178.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.665 ' N ' HD22 ' A' ' 33' ' ' ASN . 28.2 mmtp -121.79 163.72 18.65 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.105 174.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -133.94 134.19 42.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.354 0.597 . . . . 0.0 111.305 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 11.8 m-85 -140.9 136.98 32.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.673 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 58.6 m95 -102.75 108.88 20.28 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.404 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.51 112.84 25.75 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.1 t -87.6 111.94 21.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.564 0.697 . . . . 0.0 110.163 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.54 147.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.298 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.3 117.26 5.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 110.605 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.4 m -145.51 -172.47 3.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 m -60.97 -42.4 98.25 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.32 -61.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.472 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -132.96 152.45 51.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.364 0.602 . . . . 0.0 112.117 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 m -130.32 125.62 35.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -159.83 166.15 30.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.588 -172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 19.3 tt0 -105.81 117.94 35.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.25 137.49 23.04 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.584 -174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 15.0 Cg_exo -68.68 144.17 59.01 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.232 1.955 . . . . 0.0 111.665 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 42.1 mm -104.82 129.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -102.79 111.09 23.25 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -154.31 -179.99 8.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.907 0.384 . . . . 0.0 111.945 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.91 -55.51 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.99 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -126.2 176.01 7.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.693 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.55 -48.0 83.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.46 -57.93 4.23 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.099 0.874 . . . . 0.0 111.37 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 6.3 tp10 -63.26 -50.91 68.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.019 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -60.98 -39.78 90.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 0.0 111.715 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' B' ' 58' ' ' GLU . 31.2 tp -58.89 -45.59 89.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.801 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -75.63 -35.3 60.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.575 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 56.1 mt -66.53 -45.35 79.76 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.595 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -46.86 -41.75 16.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.26 0.552 . . . . 0.0 110.911 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.9 -67.11 0.81 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.28 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -19.8 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -166.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.8 tt0 -84.85 -29.88 24.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.0 0.428 . . . . 0.0 110.702 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -96.39 -33.59 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -64.41 -33.9 10.05 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.19 -0.52 10.77 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 121.695 1.597 . . . . 0.0 111.928 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.42 8.14 35.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.127 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.15 26.61 54.93 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.623 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -107.07 130.64 54.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.864 0.364 . . . . 0.0 110.738 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -97.62 113.7 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG23 ' HE2' ' B' ' 43' ' ' LYS . 29.9 m -73.72 147.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.06 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 76' ' ' ARG . 30.8 m -99.7 -58.37 1.94 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.481 ' H ' HG23 ' A' ' 39' ' ' THR . 78.3 mtm180 -152.35 177.25 10.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.227 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' B' ' 60' ' ' MET . 10.9 p -154.34 146.89 13.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -139.25 101.31 7.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.274 0.559 . . . . 0.0 110.01 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.84 137.91 79.41 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.585 2.857 . . . . 0.0 112.293 176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.57 89.28 5.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.164 0.507 . . . . 0.0 109.691 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 9.5 p -127.37 146.97 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.003 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.08 110.86 50.6 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.51 0.195 . . . . 0.0 111.424 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 81' ' ' VAL . 12.2 Cg_exo -70.96 99.65 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.909 2.406 . . . . 0.0 110.918 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.798 -174.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 -90.35 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.323 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' B' ' 66' ' ' GLN . 3.9 mm -121.44 80.97 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.623 HD12 ' HA2' ' B' ' 78' ' ' GLY . 2.2 pt? -152.24 169.32 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.392 0.615 . . . . 0.0 111.98 -169.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.09 128.32 42.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.492 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.27 -26.06 68.19 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.492 0.495 . . . . 0.0 111.756 -174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.512 HD13 ' O ' ' B' ' 55' ' ' ASP . 15.0 pt -137.2 163.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' B' ' 50' ' ' PRO . 26.2 t -87.65 140.08 29.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.213 0.53 . . . . 0.0 110.058 178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.632 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 153.14 -155.72 26.3 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.781 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.07 107.63 20.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.163 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 3.5 p -78.54 119.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.964 0.411 . . . . 0.0 110.036 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.14 169.51 11.63 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 22.9 m-85 -125.95 140.99 52.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.939 0.4 . . . . 0.0 110.685 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.508 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -120.75 -169.68 13.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.92 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.89 137.08 46.24 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.061 0.458 . . . . 0.0 111.507 -173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.15 162.0 31.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' THR . 5.2 t -109.5 101.9 10.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.364 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 43.37 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.229 1.012 . . . . 0.0 113.498 170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.31 -4.25 85.35 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.566 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -95.39 -179.96 4.96 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 38.0 ttm180 -159.86 127.99 4.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 61.2 ttt180 -80.55 107.11 13.08 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.652 -0.655 . . . . 0.0 110.244 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.523 HD22 HG13 ' B' ' 61' ' ' ILE . 18.0 tp -84.17 110.82 18.82 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.1 102.23 13.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.21 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.534 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 19.5 mt -91.81 111.15 23.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 62.1 m -84.41 99.79 0.9 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.304 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 17.8 Cg_endo -60.96 123.88 13.81 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.929 2.419 . . . . 0.0 113.424 -174.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.632 HG22 ' HA2' ' B' ' 32' ' ' GLY . 32.6 m -104.14 -15.95 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.546 0.689 . . . . 0.0 109.361 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -117.9 84.27 2.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.329 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.16 167.47 18.77 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.889 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -112.36 49.73 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.301 0.572 . . . . 0.0 110.955 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.512 ' O ' HD13 ' B' ' 30' ' ' ILE . 3.8 m-20 -117.15 87.2 22.61 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.755 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.29 119.77 6.91 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -115.79 110.37 18.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.179 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.44 ' HB3' HD22 ' A' ' 60' ' ' LEU . 44.3 mt-10 -126.96 139.36 53.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.649 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -155.66 141.52 18.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.69 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.603 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 5.2 ttp -77.16 102.81 6.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.839 0.828 . . . . 0.0 109.543 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 49.3 mm -109.16 113.88 58.49 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.627 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 32.0 Cg_exo -59.11 155.82 37.6 Favored 'Trans proline' 0 C--N 1.329 -0.479 0 C-N-CA 122.666 2.244 . . . . 0.0 112.701 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.2 OUTLIER -67.92 -25.62 65.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -87.85 6.36 35.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.831 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' B' ' 61' ' ' ILE . 18.9 tpt180 -98.36 146.51 25.62 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' HG23 ' B' ' 26' ' ' ILE . 29.2 mm-40 -68.26 94.73 0.54 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.072 0.463 . . . . 0.0 111.115 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.83 136.91 37.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.385 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' B' ' 69' ' ' VAL . 6.9 p-10 -63.71 -54.96 27.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.209 -175.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.539 HG22 ' ND2' ' B' ' 68' ' ' ASN . 8.0 m -152.89 -175.22 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -77.66 -179.48 5.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.925 0.393 . . . . 0.0 111.386 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 11.2 pt-20 -80.4 151.29 29.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.33 0.586 . . . . 0.0 112.067 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.98 9.76 83.84 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.777 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -89.66 136.83 32.81 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.07 0.462 . . . . 0.0 110.748 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.516 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 14.6 tpt180 -89.09 117.81 28.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.65 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.03 164.61 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.452 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 36.4 tt0 -113.44 160.17 18.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -55.86 115.59 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.861 0.363 . . . . 0.0 111.553 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.623 ' HA2' HD12 ' B' ' 27' ' ' LEU . . . 89.04 -46.92 3.31 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.917 174.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.56 109.53 11.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.408 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.601 HG13 ' H ' ' B' ' 81' ' ' ILE . 3.9 p -179.74 -63.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.216 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.601 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.6 mm -120.6 -51.5 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 18.4 t -170.52 117.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.12 0.486 . . . . 0.0 110.695 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.44 140.86 47.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.458 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.184 -1.342 . . . . 0.0 111.334 -177.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 121.039 0.447 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 66' ' ' GLN . . . 175.46 101.46 0.15 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.4 m -152.28 178.51 9.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.231 0.539 . . . . 0.0 111.122 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 52' ' ' TYR . 43.4 mt -128.4 178.96 5.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.695 177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 31' ' ' VAL . 50.9 m -150.13 123.51 9.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' SER . 4.5 m 60.51 -41.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 167.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t0 61.19 75.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 118.696 0.68 . . . . 0.0 110.777 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.728 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -120.13 -27.67 5.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.208 173.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.728 ' N ' HD22 ' A' ' 33' ' ' ASN . 30.7 mmtp -117.73 170.88 8.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.199 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -127.59 135.94 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -138.79 124.67 19.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -97.9 113.21 24.97 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 122.084 -0.385 . . . . 0.0 111.721 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 77' ' ' VAL . . . -99.02 122.91 42.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.486 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 75' ' ' THR . 9.9 t -95.35 107.77 19.91 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.355 0.597 . . . . 0.0 109.474 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t -97.69 143.17 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.718 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.507 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 38.5 tt0 -121.98 108.92 13.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 111.322 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.6 p -100.35 176.11 5.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.71 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.2 t -75.89 -1.56 26.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 110.11 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -103.17 -53.04 2.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.351 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -171.95 131.63 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.424 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 p -72.85 136.41 45.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -138.23 151.53 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 -177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.06 120.52 42.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 0.0 110.408 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.3 p -124.74 132.35 24.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.251 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.47 138.27 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.292 1.994 . . . . 0.0 112.288 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.5 mm -103.83 136.43 36.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' H ' HD22 ' A' ' 29' ' ' LEU . 97.5 m-85 -117.76 113.63 22.11 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.422 -174.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -148.82 176.61 10.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -77.67 -51.78 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -137.67 174.87 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.475 ' H ' HG22 ' A' ' 55' ' ' THR . 4.6 mm? -50.81 -47.45 59.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.17 -55.09 23.29 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.877 0.37 . . . . 0.0 111.567 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 18.2 tp10 -58.77 -44.55 90.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.709 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.69 82.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' B' ' 58' ' ' GLU . 27.4 tp -57.89 -42.81 85.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 49.4 mt-10 -66.91 -49.21 66.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.265 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 91.4 mt -64.72 -46.75 80.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.21 -40.84 59.62 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 111.446 -176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' OE2' ' HD3' ' B' ' 38' ' ' LYS . 20.3 tt0 -81.06 -64.15 1.25 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.193 0.52 . . . . 0.0 110.57 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -64.31 -27.26 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -166.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 4.0 pt20 -84.75 -22.91 29.48 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.545 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -97.37 -46.92 5.9 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 34.4 m -60.5 -39.09 64.21 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -169.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 61.3 Cg_endo -70.78 -14.8 33.14 Favored 'Trans proline' 0 C--N 1.362 1.264 0 CA-C-N 121.229 1.475 . . . . 0.0 112.153 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.86 8.83 30.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.744 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.69 37.37 8.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.115 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 72.9 m-85 -126.61 124.88 40.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.0 0.429 . . . . 0.0 111.234 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -103.57 134.01 47.64 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 40' ' ' VAL . 26.0 m -84.04 175.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.556 ' HB ' HG23 ' A' ' 39' ' ' THR . 33.1 m -111.36 -46.25 3.31 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 169.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -169.85 179.97 3.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.025 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 38' ' ' ALA . 14.8 m -142.21 144.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.925 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 78' ' ' ARG . 13.6 mmm180 -117.57 87.58 26.33 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.64 127.91 9.88 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.649 2.232 . . . . 0.0 111.584 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.3 m -92.25 91.88 7.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.918 0.39 . . . . 0.0 110.342 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.83 -25.86 29.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.442 0.639 . . . . 0.0 109.463 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 83.38 20.89 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.146 173.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.67 156.46 65.94 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.302 . . . . 0.0 112.856 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.1 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 4.6 Cg_exo . . . . . 0 CA--C 1.517 -0.352 0 N-CA-C 110.671 -0.549 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.83 -145.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.054 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 23.1 mm -77.45 80.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 0.0 109.434 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -152.94 164.02 38.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.269 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.18 35.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.864 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.03 -30.62 70.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.031 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -139.11 165.56 23.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.007 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' B' ' 77' ' ' ARG . 4.8 p -90.99 121.4 32.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.286 0.565 . . . . 0.0 111.261 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.567 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 162.75 -148.21 14.86 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.768 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mm -94.48 107.13 18.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.402 HG11 HD21 ' B' ' 68' ' ' ASN . 3.5 p -79.6 124.86 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.1 p -131.14 160.11 35.71 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.224 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 90.7 m-85 -127.52 128.66 46.03 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.104 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.537 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -112.87 -145.58 9.51 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.484 -175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -52.54 141.49 20.2 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.787 0.803 . . . . 0.0 112.656 -170.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.672 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 12.0 mt-10 -126.95 142.48 51.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.205 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 51.4 p -75.13 -89.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.732 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -125.7 -49.23 1.63 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.04 0.447 . . . . 0.0 109.949 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.06 19.41 6.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.71 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 7.0 mptt -111.68 179.59 3.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 38.7 ttm180 -158.77 141.7 14.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.442 0.463 . . . . 0.0 109.926 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 43.9 ttp180 -82.69 109.31 16.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.458 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' B' ' 61' ' ' ILE . 20.4 tp -84.4 103.01 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.442 HG12 ' CG ' ' B' ' 58' ' ' GLU . 2.6 m -120.8 103.37 13.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.025 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.469 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 34.9 mt -96.1 115.79 36.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 79.5 m -92.41 101.49 5.05 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.456 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 54.8 Cg_endo -70.06 121.76 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.147 1.898 . . . . 0.0 112.094 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.567 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.0 m -113.71 -28.25 2.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.93 -52.59 8.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.245 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -104.26 -175.04 25.28 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -133.73 52.57 2.06 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.284 0.564 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -124.54 93.36 46.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.42 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.09 134.92 67.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.907 2.405 . . . . 0.0 113.04 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -146.0 109.86 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.635 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.0 mp0 -123.15 138.76 54.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.9 143.35 29.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.04 0.448 . . . . 0.0 111.368 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.412 ' HB3' HG21 ' A' ' 77' ' ' VAL . 16.2 ttp -86.4 91.37 8.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.685 0.755 . . . . 0.0 109.347 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 46' ' ' LEU . 47.4 pt -93.74 166.34 16.06 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.374 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -92.11 153.4 3.2 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.507 2.138 . . . . 0.0 112.131 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -9.5 58.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.398 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . 0.521 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -83.37 -14.9 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.883 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.687 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.401 ' HG3' HG21 ' B' ' 26' ' ' ILE . 53.0 tp60 -68.62 106.73 2.7 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.24 169.0 16.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.868 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.465 ' HB2' HG11 ' B' ' 80' ' ' VAL . 20.3 p-10 -75.14 -45.03 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.407 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -169.84 -175.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.727 ' H ' HG22 ' B' ' 69' ' ' VAL . 93.0 m-85 -76.35 177.9 6.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.408 0.549 . . . . 0.0 110.893 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.73 152.78 28.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.62 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.64 29.17 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.552 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -109.87 131.0 55.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.986 0.422 . . . . 0.0 110.816 -177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.7 116.66 21.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.669 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 22.2 m -138.79 163.69 27.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.198 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 151.05 29.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.466 ' H ' ' HB3' ' B' ' 31' ' ' SER . 48.3 ttp180 -55.52 113.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.419 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 104.83 -46.45 1.18 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.287 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.46 112.37 23.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.926 0.363 . . . . 0.0 111.619 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.502 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -175.43 -59.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.152 174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.502 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.4 mm -121.1 -51.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -162.33 128.83 3.61 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -97.01 140.64 31.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.245 0.545 . . . . 0.0 110.603 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.957 0 CA-C-O 117.924 -1.487 . . . . 0.0 110.666 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 120.878 0.371 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.43 49.74 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.59 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' HD22 ' A' ' 29' ' ' LEU . 12.6 p -145.02 -85.79 0.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.871 0.367 . . . . 0.0 110.576 176.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 28' ' ' SER . 3.1 mm? -133.73 -179.19 5.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.647 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t -179.83 -155.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.69 167.0 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.347 . . . . 0.0 110.128 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.68 17.48 8.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.658 0.266 . . . . 0.0 110.812 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -42.24 -59.01 1.95 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.897 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 12.7 mptt -100.79 141.62 33.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.994 -0.441 . . . . 0.0 110.284 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.43 119.88 27.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 39.3 m-85 -116.97 113.11 21.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.023 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.0 m95 -101.62 103.06 13.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.19 97.82 11.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.657 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 HG22 ' HB ' ' A' ' 75' ' ' THR . 97.3 m -63.01 106.63 0.86 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 171.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.35 155.37 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 34.5 tt0 -117.18 109.35 16.8 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.968 0.413 . . . . 0.0 110.491 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -93.11 162.18 14.13 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.8 m -58.94 -35.24 72.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.22 -61.27 1.96 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.98 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -153.03 160.18 42.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 111.299 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 p -97.14 144.65 26.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.451 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -155.31 161.3 41.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -97.92 126.68 43.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.4 0.619 . . . . 0.0 110.58 176.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.55 129.15 25.55 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.918 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 29.4 Cg_endo -64.91 142.47 75.6 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.796 2.331 . . . . 0.0 113.611 -175.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 17.1 mm -105.61 148.22 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.75 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -123.05 112.28 17.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.868 0.366 . . . . 0.0 110.162 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -153.7 159.64 42.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.25 -20.02 22.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 m -126.82 145.75 50.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.667 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB3' ' OE1' ' B' ' 58' ' ' GLU . 0.1 OUTLIER -56.65 -55.69 30.85 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 110.959 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 30.6 t70 -60.15 -34.21 73.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.779 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 tt0 -62.81 -43.85 97.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.405 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.32 -40.45 96.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' B' ' 58' ' ' GLU . 26.6 tp -60.19 -41.01 92.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.592 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 43.1 mt-10 -65.27 -47.04 78.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 78.1 mt -65.21 -38.17 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.434 -176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.63 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 110.653 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -81.46 -68.02 0.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.2 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -25.73 68.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.174 -165.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 48.7 tt0 -83.59 -31.55 26.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.998 0.427 . . . . 0.0 110.866 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -96.01 -31.7 12.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.501 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 35.3 m -64.62 -35.72 14.93 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 6.8 Cg_exo -75.8 -10.63 19.99 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.691 1.594 . . . . 0.0 111.576 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.66 -5.91 55.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.296 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.42 27.37 11.92 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.614 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.46 124.26 51.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.813 0.34 . . . . 0.0 111.242 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.63 113.14 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' B' ' 43' ' ' LYS . 15.4 m -64.92 163.31 2.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.874 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' THR . 97.9 m -124.7 -58.99 1.47 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.156 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -156.22 -178.22 7.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.693 HG12 ' HB3' ' B' ' 60' ' ' MET . 13.9 p -154.59 143.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -118.48 94.09 46.69 Favored Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.479 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.75 129.02 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.383 2.722 . . . . 0.0 111.025 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.3 p -76.08 86.92 2.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.643 0.735 . . . . 0.0 110.31 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.23 -83.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.713 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.704 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -104.56 -50.69 0.12 Allowed Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.338 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 13.9 Cg_endo -57.78 133.52 56.73 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 121.956 1.771 . . . . 0.0 112.242 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.113 -178.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' B' ' 84' ' ' GLY . 1.2 Cg_endo . . . . . 0 N--CA 1.474 0.38 0 N-CA-C 110.792 -0.503 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' B' ' 82' ' ' SER . . . -96.82 -154.16 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.741 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 20.1 mm -72.08 83.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.47 0.652 . . . . 0.0 109.778 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.521 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.2 pp -145.29 157.63 44.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.773 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -80.06 122.39 26.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.25 -27.59 69.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.078 0.466 . . . . 0.0 111.071 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 55' ' ' ASP . 8.4 pt -133.11 157.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.732 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -86.21 121.73 29.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.776 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 167.07 -151.45 19.36 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.769 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' B' ' 74' ' ' ARG . 34.1 mm -99.57 107.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.6 p -75.43 132.35 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 9.2 p -137.45 164.67 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.727 0.299 . . . . 0.0 110.788 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 23.4 m-85 -124.24 154.45 40.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.958 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.46 ' HA3' ' HD3' ' B' ' 45' ' ' ARG . . . -137.2 -167.95 11.23 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.33 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 131.74 43.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.278 0.561 . . . . 0.0 111.889 -173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB3' ' B' ' 43' ' ' LYS . 1.5 pp20? -131.42 162.45 30.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 26.6 p -65.34 -82.22 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -129.05 -59.47 1.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.56 35.11 4.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.773 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -111.03 -173.58 2.27 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -178.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' B' ' 61' ' ' ILE . 15.8 ttm180 -160.31 133.13 6.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.053 0.454 . . . . 0.0 110.596 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 58.5 ttt180 -82.72 98.89 9.31 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.985 -0.447 . . . . 0.0 109.97 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.55 HD22 HG13 ' B' ' 61' ' ' ILE . 25.1 tp -82.42 109.02 16.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.888 0.375 . . . . 0.0 110.3 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.416 HG12 ' CG ' ' B' ' 58' ' ' GLU . 6.6 m -126.74 109.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.284 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 44.2 mt -93.19 120.32 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.091 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 86.2 m -92.32 101.39 4.82 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.616 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 36.1 Cg_endo -65.93 135.71 42.13 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.578 2.185 . . . . 0.0 113.047 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.6 HG22 ' HA2' ' B' ' 32' ' ' GLY . 21.2 m -115.86 -9.81 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.989 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -133.1 -67.96 0.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.698 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.64 86.6 1.33 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -71.82 79.47 0.87 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.244 0.545 . . . . 0.0 111.617 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.422 ' O ' HD13 ' B' ' 30' ' ' ILE . 9.7 t70 -137.36 87.93 17.56 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.77 119.8 2.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.589 2.86 . . . . 0.0 113.442 -173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -123.59 109.61 13.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 56' ' ' LEU . 18.1 mp0 -132.1 140.19 48.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 60' ' ' MET . 30.0 tt0 -154.71 155.83 35.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 0.0 110.494 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.693 ' HB3' HG12 ' A' ' 77' ' ' VAL . 29.5 ttp -84.12 84.64 7.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 16.2 mm -94.04 118.8 67.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.951 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 65.1 Cg_endo -72.16 165.99 31.0 Favored 'Trans proline' 0 C--N 1.324 -0.726 0 C-N-CA 122.681 2.254 . . . . 0.0 113.424 -174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 0.3 OUTLIER -73.42 -18.35 61.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.888 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.85 8.73 30.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.918 177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HG2' HG23 ' B' ' 61' ' ' ILE . 16.1 tpt180 -98.75 137.81 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.381 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' B' ' 26' ' ' ILE . 20.9 pt20 -69.12 112.38 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.39 0.614 . . . . 0.0 109.497 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -85.79 157.39 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.684 -172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -64.86 -53.81 40.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.647 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.715 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.31 -177.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.715 ' H ' HG22 ' B' ' 69' ' ' VAL . 23.2 m-85 -76.94 176.84 8.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.377 0.535 . . . . 0.0 111.285 -174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 13.4 pt-20 -80.63 146.6 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.506 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.75 26.16 65.65 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.099 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -109.9 132.19 54.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.493 . . . . 0.0 111.103 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.3 tpt180 -77.94 122.24 25.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.554 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.79 170.97 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.217 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -126.08 147.0 49.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 33.2 ttm180 -50.64 114.94 1.27 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.045 0.45 . . . . 0.0 111.625 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.95 -44.77 2.02 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.164 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -90.88 112.14 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 5.7 p -171.41 -57.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.51 173.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 35.8 mm -120.15 -51.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 110.666 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' B' ' 25' ' ' ALA . 12.2 t -158.31 121.9 3.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.5 149.25 21.49 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.908 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.866 0 CA-C-O 118.025 -1.431 . . . . 0.0 111.29 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.16 -112.75 0.43 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.824 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.8 m -84.25 -20.86 31.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.277 0.561 . . . . 0.0 109.851 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.78 104.63 6.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.093 177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 t -71.01 -70.78 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.794 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 33' ' ' ASN . 7.1 p -154.02 135.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 9.5 p-10 -92.52 29.24 1.77 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.047 0.451 . . . . 0.0 111.339 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' ND2' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -54.55 -47.23 73.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.925 177.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 71.5 mmtt -97.07 167.02 11.31 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.82 102.81 10.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.192 0.52 . . . . 0.0 110.993 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' CE1' ' HG ' ' A' ' 56' ' ' LEU . 38.6 m-85 -124.55 121.11 33.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -98.84 144.78 27.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.019 0.438 . . . . 0.0 111.692 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.48 127.47 29.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.125 172.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 76' ' ' ARG . 15.2 t -96.45 121.94 38.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.582 0.706 . . . . 0.0 109.631 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.76 142.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.988 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.72 136.67 52.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.1 m -105.39 -161.21 0.79 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.133 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -60.28 -42.44 95.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.749 0.309 . . . . 0.0 111.55 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.15 -31.89 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -111.81 157.56 20.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.839 0.352 . . . . 0.0 111.441 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -132.68 140.77 48.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.076 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.6 166.02 25.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.67 0.272 . . . . 0.0 111.116 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 9.8 pt-20 -114.47 135.33 54.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.077 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.06 136.59 14.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.383 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.26 146.6 57.54 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.467 2.111 . . . . 0.0 112.11 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 63' ' ' ALA . 43.3 mm -105.41 129.3 58.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.702 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 32' ' ' ASP . 1.2 m-85 -96.21 110.85 23.07 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.26 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 58' ' ' GLU . . . -154.56 155.82 35.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.33 -53.5 35.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.407 . . . . 0.0 110.695 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.0 m -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.753 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.554 ' HG ' ' CE1' ' A' ' 36' ' ' PHE . 3.2 tt -59.5 -44.27 93.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -51.97 -38.3 56.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.329 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.7 tp10 -71.21 -46.48 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.51 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -62.56 -38.12 88.81 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.079 0.466 . . . . 0.0 110.679 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 58' ' ' GLU . 25.7 tp -52.66 -44.32 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.532 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 17.7 mm-40 -72.81 -56.69 4.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.653 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 77.0 mt -56.52 -39.56 73.54 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.436 ' HB2' HG13 ' A' ' 51' ' ' ILE . . . -46.72 -50.59 17.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.295 0.569 . . . . 0.0 111.181 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.94 -57.62 3.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.833 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -59.25 -26.04 64.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.846 -168.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 40.2 tt0 -83.92 -40.72 18.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.87 0.367 . . . . 0.0 111.33 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -90.36 -25.61 20.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 29.2 m -66.46 -35.81 10.9 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.488 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 8.1 Cg_exo -74.06 -4.6 15.69 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.587 1.524 . . . . 0.0 111.847 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.83 2.79 52.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.211 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.89 25.27 35.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.394 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 84.2 m-85 -117.07 153.36 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.282 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -122.81 127.4 49.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.144 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' HE2' ' B' ' 43' ' ' LYS . 24.5 m -70.57 152.77 8.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 21.1 m -114.45 -44.57 3.08 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.866 0.365 . . . . 0.0 110.337 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.429 ' O ' HG22 ' A' ' 39' ' ' THR . 7.8 mtp180 -162.51 168.18 22.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.713 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG21 ' H ' ' B' ' 60' ' ' MET . 25.4 m -136.83 157.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.043 0.449 . . . . 0.0 111.157 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 78' ' ' ARG . 2.0 tpm_? -136.99 81.42 33.18 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.318 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.09 128.49 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.71 2.273 . . . . 0.0 111.925 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.8 t -108.12 111.91 24.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.34 106.95 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.55 117.99 66.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.309 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.55 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.991 2.46 . . . . 0.0 112.749 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' C ' ' HZ3' ' A' ' 34' ' ' LYS . 12.9 tmtt? . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.574 ' HA ' ' OXT' ' B' ' 84' ' ' GLY . 2.2 Cg_endo . . . . . 0 N--CA 1.473 0.295 0 N-CA-C 110.858 -0.478 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.04 -146.37 0.25 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' B' ' 66' ' ' GLN . 9.5 mm -78.6 76.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.492 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.3 pp -146.91 169.53 18.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.57 -172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -100.4 137.45 38.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.888 173.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -73.5 -15.6 61.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.137 0.494 . . . . 0.0 110.911 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' B' ' 50' ' ' PRO . 8.0 pt -146.14 156.07 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.567 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' B' ' 76' ' ' GLU . 19.2 t -87.57 138.44 31.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.642 0.734 . . . . 0.0 109.853 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.32 -154.23 25.3 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.769 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.9 mm -100.72 108.6 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 4.8 p -79.71 130.18 36.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.933 0.397 . . . . 0.0 110.285 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -132.11 172.36 12.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.27 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 31.3 m-85 -129.9 145.35 51.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.266 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -121.81 -163.01 11.8 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.153 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.57 142.04 29.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.147 0.499 . . . . 0.0 111.589 -175.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 161.29 31.68 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.5 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' B' ' 41' ' ' LYS . 1.7 m -66.89 -78.99 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 110.855 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.406 ' H ' ' HB ' ' B' ' 40' ' ' THR . 49.7 mttp -138.25 -66.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.08 40.64 2.37 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.941 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 12.3 mptt -122.16 179.76 4.43 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.289 -0.536 . . . . 0.0 110.655 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.402 ' HD2' ' CD1' ' B' ' 67' ' ' LEU . 37.5 ttm180 -159.45 115.16 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.539 175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 48.3 ttp180 -74.13 99.72 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.284 -172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -71.64 114.18 9.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.589 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.12 103.87 10.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.363 0.601 . . . . 0.0 110.075 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 31.3 mt -89.53 133.63 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 33.7 m -100.01 97.25 5.78 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.117 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HB3' HD12 ' B' ' 30' ' ' ILE . 20.5 Cg_endo -61.91 126.64 19.32 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.585 2.19 . . . . 0.0 112.599 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.415 HG22 ' HA2' ' B' ' 32' ' ' GLY . 34.4 m -100.98 -10.57 8.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.292 0.568 . . . . 0.0 109.772 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.34 103.39 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.695 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.97 -28.8 3.16 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.578 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m 56.12 40.17 30.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.322 0.582 . . . . 0.0 111.42 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.436 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.1 t70 -120.19 85.95 36.92 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.316 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.13 132.08 47.13 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.042 2.495 . . . . 0.0 112.655 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -130.93 110.95 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.131 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.543 ' HB3' HD22 ' A' ' 60' ' ' LEU . 24.1 mp0 -122.68 144.87 48.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -153.78 139.48 17.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.05 0.452 . . . . 0.0 110.708 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.462 ' H ' HG21 ' A' ' 77' ' ' VAL . 12.2 ttp -84.67 89.78 7.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.558 0.694 . . . . 0.0 109.966 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . . . . . . . . . 36.8 mt -96.82 134.61 22.87 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.994 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 34.6 Cg_endo -64.12 151.76 83.99 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.528 2.152 . . . . 0.0 112.736 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -70.99 -13.3 61.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.922 -175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -0.91 57.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.382 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -89.78 138.73 31.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.088 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' B' ' 26' ' ' ILE . 24.9 tp60 -68.13 107.13 2.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HD2' ' B' ' 44' ' ' ARG . 69.4 mt -87.91 164.36 15.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.176 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.42 -50.67 68.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.236 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.708 HG22 ' H ' ' B' ' 70' ' ' PHE . 8.7 p -168.34 -176.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.708 ' H ' HG22 ' B' ' 69' ' ' VAL . 96.7 m-85 -77.18 174.75 10.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 10.0 pt-20 -80.58 144.62 32.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.285 0.565 . . . . 0.0 111.994 -175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 15.94 76.85 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.134 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -103.01 146.64 28.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.198 0.523 . . . . 0.0 110.888 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 74' ' ' ARG . 8.8 tpt180 -89.07 125.26 34.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.748 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.85 174.2 13.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.491 ' HA ' ' CB ' ' B' ' 31' ' ' SER . 28.8 tt0 -127.76 163.63 23.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 57.3 ttt180 -65.7 113.96 4.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.917 0.389 . . . . 0.0 110.84 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.05 -42.54 3.16 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.477 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.17 111.46 19.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.522 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.55 HG13 ' H ' ' B' ' 81' ' ' ILE . 4.0 p -174.52 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.741 172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.55 ' H ' HG13 ' B' ' 80' ' ' VAL . 38.9 mm -120.82 -49.88 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.457 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -163.66 130.95 3.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.452 ' HA ' HD23 ' B' ' 27' ' ' LEU . 8.5 p-10 -89.06 144.98 25.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.734 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.574 ' OXT' ' HA ' ' B' ' 24' ' ' PRO . . . . . . . . 0 C--O 1.246 0.871 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.748 0.309 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.37 128.1 1.46 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.765 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p -102.75 -179.51 3.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.937 0.398 . . . . 0.0 110.725 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.81 116.47 31.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 6.8 m -85.9 -168.67 2.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.281 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.9 p -68.06 150.22 11.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 6.3 p-10 -123.39 47.84 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.071 0.463 . . . . 0.0 111.591 -174.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' ND2' ' HG2' ' A' ' 34' ' ' LYS . 1.3 p-10 -75.57 -35.43 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 33.1 mmtp -98.78 167.34 10.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -119.43 122.91 42.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.188 0.518 . . . . 0.0 110.728 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 52.0 m-85 -136.26 130.65 33.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.593 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -111.33 108.57 18.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.698 0.285 . . . . 0.0 110.971 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 107.22 19.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.5 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 m -76.44 96.1 3.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.641 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 74' ' ' VAL . 23.3 m -103.55 153.78 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.861 0.362 . . . . 0.0 110.526 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -112.56 110.28 20.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.029 0.443 . . . . 0.0 109.902 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 t -93.45 -179.91 5.19 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.664 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.6 m -62.82 -42.1 99.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.79 0.329 . . . . 0.0 111.732 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -92.3 -46.35 7.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.421 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -149.83 142.45 24.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.712 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -90.04 139.67 30.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.308 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.41 163.6 37.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.753 0.311 . . . . 0.0 110.775 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.96 118.0 33.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.39 129.05 24.73 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.996 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 19.7 Cg_endo -61.82 141.26 89.53 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.91 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 63' ' ' ALA . 42.7 mm -104.22 134.31 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' SER . 62.0 m-85 -109.52 112.65 24.87 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -174.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.13 166.94 32.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.601 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -73.95 -54.24 8.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.93 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.5 m -121.01 160.76 22.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.824 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' H ' ' B' ' 58' ' ' GLU . 41.4 tp -55.16 -50.21 69.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.98 -34.36 71.72 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.099 0.476 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -69.1 -39.94 78.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.27 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -66.97 -41.27 87.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.116 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 17.4 tp -58.31 -42.14 86.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.115 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.86 -49.5 75.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.939 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.61 -35.36 70.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.06 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -50.99 -52.75 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -81.95 -58.68 2.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.849 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -34.34 77.44 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -84.62 -25.42 28.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 111.077 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 10.2 m-85 -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' CG2' ' HD3' ' A' ' 69' ' ' PRO . 27.9 m -62.61 -36.13 24.52 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 2.8 Cg_exo -78.27 -15.76 14.13 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.706 1.604 . . . . 0.0 111.598 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.48 -9.41 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.676 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.26 24.76 7.37 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.966 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 93.7 m-85 -113.92 107.49 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.603 -0.351 . . . . 0.0 110.309 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -83.61 95.18 8.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG12 HG12 ' A' ' 40' ' ' VAL . 27.5 m -57.77 135.38 21.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.567 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 51.0 m -110.44 -53.79 2.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.431 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -143.79 179.8 6.93 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.579 HG11 ' H ' ' B' ' 60' ' ' MET . 8.1 p -152.96 150.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.34 93.42 8.95 Favored Pre-proline 0 C--N 1.317 -0.805 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.547 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -67.3 164.27 31.19 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.022 2.481 . . . . 0.0 111.489 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.3 p -66.78 89.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 0.0 110.265 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.1 p -79.08 77.88 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.164 0.983 . . . . 0.0 111.445 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.92 74.7 80.86 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.462 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.65 88.47 1.42 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.067 2.511 . . . . 0.0 112.289 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.583 177.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.477 0.532 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.464 ' H ' ' CD2' ' B' ' 27' ' ' LEU . . . -113.4 -130.38 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.949 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' B' ' 66' ' ' GLN . 22.2 mm -84.2 77.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -153.28 174.19 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.531 -172.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -99.5 130.79 45.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.097 171.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.28 -23.94 66.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.317 0.579 . . . . 0.0 111.039 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' B' ' 50' ' ' PRO . 9.3 pt -139.62 165.99 21.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 16.0 t -97.66 136.32 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.609 0.719 . . . . 0.0 110.478 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 161.99 -150.33 19.59 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.055 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.74 108.4 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 5.7 p -85.23 133.2 29.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.44 169.39 16.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.422 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 33.7 m-85 -128.08 129.74 47.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.134 0.492 . . . . 0.0 110.609 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.506 ' HA3' ' NE ' ' B' ' 45' ' ' ARG . . . -104.47 -167.51 24.63 Favored Glycine 0 C--O 1.239 0.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.187 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.406 ' C ' ' HD2' ' B' ' 38' ' ' LYS . 0.0 OUTLIER -54.69 136.41 45.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.183 0.516 . . . . 0.0 111.865 -174.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 161.8 32.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.411 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.474 HG21 HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -70.04 -85.23 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 176.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -130.93 -73.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.166 0.508 . . . . 0.0 110.319 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.86 26.74 15.05 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 75' ' ' THR . 4.6 tptp -109.13 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.665 0.269 . . . . 0.0 110.353 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.521 ' O ' HG22 ' B' ' 61' ' ' ILE . 19.2 ttm180 -160.7 118.66 2.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.374 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 31.4 ttp180 -76.83 98.73 4.93 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.617 -0.677 . . . . 0.0 110.65 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' B' ' 59' ' ' GLU . 15.6 tp -77.55 109.9 11.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.682 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' B' ' 58' ' ' GLU . 19.9 m -125.21 105.72 15.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.348 0.594 . . . . 0.0 110.334 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 48.1 mt -91.21 119.08 37.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.916 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 46.9 m -92.91 99.13 2.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.281 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.556 ' HB3' HD12 ' B' ' 30' ' ' ILE . 31.6 Cg_endo -65.17 139.1 59.15 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.969 2.446 . . . . 0.0 113.416 -175.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.463 HG22 ' HA2' ' B' ' 32' ' ' GLY . 26.0 m -118.39 -11.76 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.162 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -102.43 -64.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.602 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . -108.16 134.69 12.37 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -77.83 64.94 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.401 0.619 . . . . 0.0 111.426 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HD13 ' B' ' 30' ' ' ILE . 28.9 t70 -135.04 88.52 26.47 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.139 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.88 145.12 74.8 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.084 2.523 . . . . 0.0 112.932 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -137.75 109.65 7.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.605 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 6.8 mp0 -128.48 145.82 51.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.996 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.499 ' HG2' HD23 ' B' ' 46' ' ' LEU . 7.8 pt-20 -159.49 167.24 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.524 0.678 . . . . 0.0 111.048 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.579 ' H ' HG11 ' A' ' 77' ' ' VAL . 36.0 ttp -90.43 75.19 6.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.886 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.521 HG22 ' O ' ' B' ' 44' ' ' ARG . 9.0 tt -77.04 143.77 70.88 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' B' ' 65' ' ' ARG . 3.4 Cg_exo -83.36 158.58 14.85 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.282 1.988 . . . . 0.0 113.18 177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 -19.39 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.847 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -86.98 -1.13 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.812 176.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 11.9 tpp85 -79.48 144.25 34.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.248 172.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.459 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.6 tp60 -69.32 109.09 3.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -84.34 157.61 21.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.957 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -75.8 -46.29 31.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.713 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.9 p -168.3 -177.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.713 ' H ' HG22 ' B' ' 69' ' ' VAL . 89.6 m-85 -78.84 177.21 8.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.81 0.338 . . . . 0.0 110.837 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.483 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.7 pt-20 -80.41 146.66 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.856 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.61 28.11 68.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.261 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -111.17 142.52 43.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.123 0.487 . . . . 0.0 110.868 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 tpt85 -88.13 118.43 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.047 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.65 171.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.135 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.53 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 25.9 tt0 -123.42 164.26 19.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 64.9 ttt180 -63.89 114.05 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.756 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 86.63 -39.78 3.07 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.021 176.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.96 111.13 19.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.149 0.5 . . . . 0.0 111.389 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.61 HG13 ' H ' ' B' ' 81' ' ' ILE . 5.4 p -176.06 -65.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.795 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.61 ' H ' HG13 ' B' ' 80' ' ' VAL . 47.4 mm -121.17 -52.08 3.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 O-C-N 122.024 -0.422 . . . . 0.0 110.906 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 20.6 t -156.62 120.8 4.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.914 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.545 ' HA ' HD23 ' B' ' 27' ' ' LEU . 5.1 p-10 -98.16 144.82 27.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.217 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.021 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.618 0.247 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.77 55.15 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -154.44 -80.64 0.09 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.693 0.282 . . . . 0.0 111.275 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.5 tp -166.74 129.28 1.81 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.9 p -109.59 -63.27 1.38 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 33' ' ' ASN . 10.5 p -156.89 131.59 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.832 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.08 20.84 14.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.985 0.421 . . . . 0.0 111.067 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -50.85 -46.95 60.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.501 178.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' H ' ' ND2' ' A' ' 33' ' ' ASN . 32.8 mmtp -97.19 164.24 12.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.55 86.98 2.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.158 0.504 . . . . 0.0 110.716 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . 38.9 m-85 -103.31 141.58 35.67 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -127.49 135.86 50.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.667 0.27 . . . . 0.0 111.224 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -127.33 122.77 34.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.806 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.8 m -84.83 120.24 26.23 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 14.9 m -118.77 152.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 111.21 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.43 118.61 26.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 t -85.55 -159.92 0.48 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.186 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -49.03 -38.75 24.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -139.85 -49.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 111.464 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -74.95 156.23 36.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.626 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 p -142.45 146.5 34.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.921 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -165.11 168.71 16.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.794 0.33 . . . . 0.0 111.445 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.25 118.57 37.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.731 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 p -117.69 135.87 23.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.689 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' VAL . 27.9 Cg_exo -61.66 140.16 84.88 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 50.7 mm -106.37 129.69 59.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.225 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -103.76 111.44 23.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.012 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.75 174.05 15.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.444 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -92.64 -52.68 4.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.203 0.525 . . . . 0.0 110.762 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -112.69 163.59 14.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.994 -172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' VAL . 3.5 mm? -55.34 -60.75 2.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 111.607 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -60.19 -33.07 71.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.173 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.99 -44.95 91.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.09 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.85 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.863 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' B' ' 58' ' ' GLU . 14.4 tp -56.13 -48.7 75.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.678 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' TRP . 9.9 pt-20 -70.73 -39.61 73.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.812 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 67.7 mt -68.56 -45.08 73.05 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 51' ' ' ILE . . . -45.76 -45.0 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 111.001 -176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -81.99 -63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.322 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -63.94 -22.64 67.01 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -166.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 7.1 tt0 -83.69 -33.21 25.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.782 0.325 . . . . 0.0 111.077 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -95.18 -33.64 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 36.0 m -62.78 -34.03 13.05 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 68' ' ' VAL . 36.7 Cg_endo -65.83 -15.3 48.46 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 121.441 1.427 . . . . 0.0 112.117 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.98 6.16 49.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.733 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.93 9.54 67.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.496 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -98.94 91.04 4.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.654 0.264 . . . . 0.0 111.053 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HG3' HG21 ' B' ' 40' ' ' THR . 45.2 tt0 -78.97 112.2 15.91 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.929 175.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG21 ' SD ' ' B' ' 60' ' ' MET . 31.3 m -56.18 150.99 2.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 174.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HE3' ' B' ' 43' ' ' LYS . 19.7 p -118.72 -55.02 2.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.994 0.426 . . . . 0.0 110.384 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -138.05 163.08 32.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG21 ' H ' ' B' ' 60' ' ' MET . 21.3 m -141.34 157.72 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -143.55 90.62 7.07 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.116 173.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.27 127.96 8.63 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.901 2.401 . . . . 0.0 111.803 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.9 m -101.52 109.51 21.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.06 0.457 . . . . 0.0 110.062 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 56' ' ' LEU . 22.1 t -71.49 128.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.446 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.62 87.48 56.36 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.121 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -67.15 -43.65 6.07 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.756 2.304 . . . . 0.0 111.617 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.536 179.738 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.508 ' HA ' HD21 ' B' ' 27' ' ' LEU . 1.6 Cg_endo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.638 -0.562 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.75 -92.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' B' ' 66' ' ' GLN . 19.3 mm -115.46 77.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.639 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.8 pp -157.95 172.92 17.58 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.468 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 77' ' ' ARG . . . -91.02 118.51 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.48 -9.98 57.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.286 0.565 . . . . 0.0 110.582 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.404 HD13 ' O ' ' B' ' 55' ' ' ASP . 18.8 pt -139.67 150.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.508 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.589 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 15.4 t -82.61 131.6 35.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.582 0.706 . . . . 0.0 110.219 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 163.87 -148.41 14.66 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.338 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' B' ' 73' ' ' GLU . 28.9 mm -106.44 114.63 46.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.421 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 71' ' ' GLU . 48.3 t -69.64 126.37 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 11.6 p -135.12 160.74 37.38 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.083 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 52.9 m-85 -127.12 159.11 35.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.549 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 45' ' ' ARG . . . -142.83 -158.94 7.73 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.744 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' B' ' 38' ' ' LYS . 0.1 OUTLIER -54.84 139.75 38.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.21 -173.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 161.58 31.89 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.656 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -58.94 -69.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.323 0.582 . . . . 0.0 111.229 -176.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -159.65 -53.02 0.06 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.19 33.98 5.43 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.334 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.458 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -116.09 -175.32 2.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 36' ' ' PHE . 38.9 ttm180 -159.87 119.24 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.652 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 55.6 ttt180 -71.67 104.84 3.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.742 -0.598 . . . . 0.0 111.226 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 45.7 tp -85.15 104.36 14.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.035 0.445 . . . . 0.0 110.783 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -123.21 111.18 28.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.977 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.472 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 46.3 mt -97.34 124.19 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.018 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -91.46 98.87 1.96 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.421 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' B' ' 48' ' ' ILE . 35.4 Cg_endo -66.09 129.0 20.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.238 -177.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.667 HG22 ' HA2' ' B' ' 32' ' ' GLY . 17.9 m -114.77 -34.77 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.564 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 31' ' ' SER . 32.5 t70 -81.77 -39.13 24.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.281 0.562 . . . . 0.0 109.526 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.46 -172.54 18.25 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 4.5 t -138.22 40.34 2.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.645 0.736 . . . . 0.0 109.803 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . 6.1 t70 -107.99 98.24 24.98 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.58 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.82 127.05 23.0 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.63 2.22 . . . . 0.0 112.449 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -135.27 109.05 8.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.882 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' A' ' 60' ' ' LEU . 5.1 mp0 -128.82 141.93 51.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.73 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -156.04 169.5 24.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.411 0.624 . . . . 0.0 110.734 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 74' ' ' VAL . 6.9 ttp -98.82 94.08 6.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.705 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' B' ' 62' ' ' PRO . 8.2 tp -91.97 136.39 26.16 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.186 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 11.7 Cg_exo -72.48 152.75 54.83 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.834 1.689 . . . . 0.0 113.101 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -74.56 -24.71 58.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.115 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . 0.402 ' CZ2' ' HB3' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -88.88 -2.93 58.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.495 179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 7.0 tpt180 -83.24 138.9 33.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.158 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' B' ' 26' ' ' ILE . 21.6 pt20 -68.46 115.48 7.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 58.5 mt -93.59 165.59 12.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.426 -170.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -70.7 -53.99 13.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.623 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.2 p -168.37 179.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.623 ' H ' HG22 ' B' ' 69' ' ' VAL . 98.0 m-85 -77.79 178.18 7.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.103 0.478 . . . . 0.0 111.162 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' B' ' 34' ' ' VAL . 10.6 pt-20 -81.39 148.72 29.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.299 0.571 . . . . 0.0 111.7 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 34' ' ' VAL . . . 75.05 27.26 64.68 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.553 -176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 33' ' ' ILE . 24.6 mm-40 -109.83 139.91 44.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.573 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.4 tpt85 -95.77 119.53 34.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.413 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.24 163.02 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.215 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.589 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -107.11 161.02 15.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' B' ' 28' ' ' ALA . 72.5 ttt180 -54.83 113.12 1.21 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.454 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.443 ' HA2' HD22 ' B' ' 27' ' ' LEU . . . 97.38 -38.76 2.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.475 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -90.69 113.52 25.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.639 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.2 p -175.69 -61.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.746 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.518 ' H ' HG13 ' B' ' 80' ' ' VAL . 48.0 mm -121.97 -52.09 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.986 -0.446 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.1 t -158.36 121.57 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.628 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.575 ' HA ' HD23 ' B' ' 27' ' ' LEU . 9.7 p-10 -105.99 134.56 48.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.529 0.681 . . . . 0.0 111.289 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 CA-C-O 118.185 -1.342 . . . . 0.0 110.84 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.977 0.417 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.72 0.33 89.58 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.911 -0.662 . . . . 0.0 114.005 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -148.92 -85.12 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.752 0.776 . . . . 0.0 111.941 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -107.12 112.35 25.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.104 0.478 . . . . 0.0 111.786 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -102.26 -62.13 1.3 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.2 p -160.09 142.48 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.43 32.86 2.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.879 0.371 . . . . 0.0 111.973 -173.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.728 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -72.17 -26.72 62.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.731 0.777 . . . . 0.0 110.082 174.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.728 ' N ' HD22 ' A' ' 33' ' ' ASN . 69.8 mmtt -122.21 169.85 10.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.322 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -142.68 127.63 18.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.034 0.445 . . . . 0.0 109.988 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 14.7 m-85 -133.24 122.2 23.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -98.35 105.94 18.16 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.515 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.01 114.93 28.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -86.18 116.82 24.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 74' ' ' VAL . 18.4 m -113.58 154.9 14.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.198 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 36.8 tt0 -133.81 108.46 8.48 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.07 0.462 . . . . 0.0 110.183 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -103.63 -174.59 2.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.835 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -72.11 -20.53 61.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.6 -58.54 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.03 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -167.65 155.17 8.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.6 0.238 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.578 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -96.38 127.72 42.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -156.11 166.27 33.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.158 0.504 . . . . 0.0 111.749 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.23 122.9 41.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.401 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.62 128.45 23.54 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.146 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 59.8 Cg_endo -74.48 142.94 30.27 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 113.06 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 36' ' ' PHE . 9.3 mm -105.11 144.77 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -133.68 119.53 19.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.67 0.271 . . . . 0.0 110.925 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -153.49 -178.92 7.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.422 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -68.11 -56.51 8.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 56' ' ' LEU . 8.2 m -134.65 165.95 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.0 -172.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 36' ' ' PHE . 3.9 mm? -45.78 -58.44 3.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.565 0.746 . . . . 0.0 112.48 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 5.2 p-10 -54.28 -41.02 68.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.83 -45.19 62.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.346 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.56 -39.93 89.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.61 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' B' ' 58' ' ' GLU . 32.9 tp -60.81 -42.39 97.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.747 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 57' ' ' ASP . 47.7 mt-10 -65.23 -51.02 63.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.323 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 74.6 mt -67.1 -33.07 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.506 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . -54.12 -52.96 59.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.736 0.303 . . . . 0.0 110.902 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 68' ' ' VAL . 35.3 tt0 -81.79 -60.29 2.29 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.762 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.28 -31.85 73.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -166.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 25.7 tp60 -85.0 -25.34 27.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.31 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 4.2 m-85 -92.79 -42.26 9.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 33.6 m -62.89 -37.61 35.31 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 11.2 Cg_exo -72.0 -13.54 28.93 Favored 'Trans proline' 0 C--N 1.359 1.131 0 CA-C-N 121.276 1.491 . . . . 0.0 111.955 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.34 2.71 54.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.31 1.19 41.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.506 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 17.8 m-85 -92.03 165.55 13.13 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.93 106.65 3.67 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 40' ' ' VAL . 19.4 m -62.5 152.18 7.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.491 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 m -114.57 -61.63 1.72 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -145.7 157.87 43.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' B' ' 60' ' ' MET . 25.9 m -131.53 146.68 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.155 0.502 . . . . 0.0 111.227 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -110.44 91.37 11.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.095 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 77' ' ' VAL . 7.8 Cg_exo -75.38 150.56 36.74 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.009 2.473 . . . . 0.0 112.37 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.1 p -81.35 89.37 6.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.241 0.543 . . . . 0.0 111.021 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.2 p -93.19 152.79 3.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.77 112.96 5.71 Favored Pre-proline 0 C--N 1.328 -0.351 0 O-C-N 123.162 0.289 . . . . 0.0 111.007 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.75 60.69 7.78 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.785 2.323 . . . . 0.0 111.665 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 C--O 1.246 0.889 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.759 -177.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.478 0.61 0 N-CA-C 110.549 -0.596 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 -143.18 0.31 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.326 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 81' ' ' ILE . 22.6 mm -74.2 81.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.107 0.48 . . . . 0.0 109.716 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 4.0 pp -156.24 167.44 30.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.62 128.44 38.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -64.95 -21.31 66.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.26 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' B' ' 50' ' ' PRO . 14.2 pt -139.24 163.07 26.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.058 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 17.6 t -95.06 135.81 36.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.321 0.581 . . . . 0.0 110.279 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.707 ' HA2' HG22 ' B' ' 51' ' ' VAL . . . 159.84 -156.37 27.56 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.336 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 42.4 mm -97.65 107.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 6.9 p -83.26 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.413 ' OG ' HG23 ' B' ' 47' ' ' VAL . 5.5 p -137.9 164.25 29.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.736 -176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 20.6 m-85 -111.75 155.24 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.51 14.99 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.292 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.68 129.83 34.41 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.628 0.728 . . . . 0.0 111.955 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' B' ' 43' ' ' LYS . 0.0 OUTLIER -130.94 164.11 26.03 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.322 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -58.02 -78.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.932 0.396 . . . . 0.0 111.392 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -160.84 -37.78 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.707 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.97 9.1 50.77 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.009 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -116.86 -175.61 2.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.336 0.589 . . . . 0.0 111.505 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.612 ' CZ ' HD11 ' B' ' 67' ' ' LEU . 21.1 ttp180 -160.49 109.2 1.66 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.811 -178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 33.5 ttt180 -71.32 103.79 2.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.67 -171.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 tp -85.76 105.5 16.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.413 HG23 ' OG ' ' B' ' 35' ' ' SER . 15.5 m -116.8 115.47 49.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.068 0.461 . . . . 0.0 110.123 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 37.1 mt -97.54 137.74 24.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 0.0 110.26 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 91.6 m -106.53 88.72 3.55 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.727 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' B' ' 31' ' ' SER . 27.4 Cg_endo -63.58 123.48 12.13 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.983 2.455 . . . . 0.0 113.314 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.707 HG22 ' HA2' ' B' ' 32' ' ' GLY . 24.4 m -110.67 -10.03 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.924 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' B' ' 31' ' ' SER . 46.1 m-20 -112.28 41.76 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.148 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 50' ' ' PRO . . . 142.83 148.84 5.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.936 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 p -90.3 64.07 5.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.427 0.632 . . . . 0.0 110.844 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.11 91.16 48.63 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.61 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.29 137.67 57.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.782 2.322 . . . . 0.0 112.199 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -150.42 109.57 3.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.388 0.613 . . . . 0.0 110.397 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.457 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 5.8 mp0 -125.52 129.85 50.58 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.871 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.19 177.33 8.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 112.043 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.554 ' O ' ' HD3' ' B' ' 62' ' ' PRO . 16.9 tpp -98.0 90.85 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.39 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' B' ' 44' ' ' ARG . 21.2 mm -89.71 107.97 22.35 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' B' ' 60' ' ' MET . 34.5 Cg_exo -61.7 158.76 35.78 Favored 'Trans proline' 0 C--N 1.328 -0.519 0 C-N-CA 122.326 2.017 . . . . 0.0 112.225 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -23.02 64.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.614 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . 0.416 ' CE2' ' HB3' ' B' ' 62' ' ' PRO . 1.1 p-90 -92.27 11.44 25.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.081 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -97.07 136.86 37.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.685 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.419 ' HG3' HG21 ' B' ' 26' ' ' ILE . 6.1 tp-100 -68.88 127.1 31.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.451 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' B' ' 44' ' ' ARG . 40.2 mt -93.68 153.55 18.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.141 -173.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -74.49 -41.32 60.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.721 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.8 p -169.41 179.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.644 ' H ' HG22 ' B' ' 69' ' ' VAL . 70.5 m-85 -78.38 179.14 7.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.912 0.387 . . . . 0.0 110.856 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 11.1 pt-20 -80.49 152.6 28.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.226 0.536 . . . . 0.0 111.952 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.76 28.45 73.5 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.489 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -113.21 148.25 35.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.091 0.472 . . . . 0.0 110.745 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -93.71 117.1 29.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.54 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.81 156.79 38.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.396 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.627 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 30.2 tt0 -106.68 157.65 17.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.524 ' H ' ' HB2' ' B' ' 31' ' ' SER . 73.7 ttt180 -54.91 115.58 2.27 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.784 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.44 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 85.99 -45.21 3.44 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.86 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -80.27 111.61 16.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.664 0.268 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 6.7 p -174.98 -58.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.493 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' B' ' 26' ' ' ILE . 47.4 mm -121.08 -52.99 3.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.821 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 15.4 t -173.16 139.99 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.991 0.424 . . . . 0.0 110.767 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.37 146.35 26.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.891 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.182 177.589 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.736 0.303 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 62' ' ' LEU . . . 160.43 44.68 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.642 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -114.06 174.57 5.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.369 0.604 . . . . 0.0 111.604 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 52' ' ' TYR . 10.2 mp -85.43 101.11 12.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.669 176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -64.06 -63.01 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.568 -175.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.13 -38.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.787 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 t70 64.18 74.55 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.388 0.613 . . . . 0.0 111.086 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -95.74 -29.75 14.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.468 175.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.65 ' N ' HD22 ' A' ' 33' ' ' ASN . 4.6 mptp? -106.04 -174.84 2.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -126.5 135.27 51.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 110.647 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 20.4 m-85 -136.9 113.86 10.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.05 112.21 24.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.493 0.187 . . . . 0.0 111.043 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.92 123.27 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -82.74 112.78 19.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -117.44 134.7 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.017 0.437 . . . . 0.0 110.593 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 18.8 tt0 -112.73 124.28 52.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.492 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 p -104.65 -174.72 2.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.328 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.0 p -68.53 -18.97 64.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.262 0.553 . . . . 0.0 110.191 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.28 -61.15 1.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.22 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -163.61 173.92 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.682 0.277 . . . . 0.0 110.564 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HG3' ' A' ' 41' ' ' GLU . 1.5 m -94.89 127.59 41.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.16 159.07 42.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.807 0.337 . . . . 0.0 110.638 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -111.48 135.8 51.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 7.4 p -132.86 131.34 21.94 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.633 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 9.2 Cg_exo -71.75 143.58 41.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.607 2.205 . . . . 0.0 113.008 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG13 ' HE2' ' A' ' 67' ' ' TYR . 1.8 mp -106.25 135.24 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.817 173.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.443 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 m-85 -101.32 109.82 21.73 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 30' ' ' SER . . . -150.05 -179.6 7.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.988 0.423 . . . . 0.0 111.761 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.88 -59.95 2.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -128.0 172.15 11.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' B' ' 57' ' ' TYR . 9.8 mp -55.06 -45.65 75.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 61' ' ' GLU . 18.2 t70 -54.58 -50.85 67.01 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.243 0.339 . . . . 0.0 111.145 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 9.8 tp10 -60.37 -45.31 93.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.431 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.15 94.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HG ' ' NH1' ' B' ' 45' ' ' ARG . 21.4 tp -65.11 -38.79 91.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.261 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 57' ' ' ASP . 71.8 mm-40 -59.74 -51.36 70.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.428 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 27' ' ' GLY . 67.6 mt -66.24 -42.46 88.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.82 -42.52 47.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.05 0.452 . . . . 0.0 110.953 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 68' ' ' VAL . 51.6 tt0 -81.24 -66.03 0.94 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -25.31 64.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -164.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 34.5 tt0 -83.7 -30.62 26.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.19 0.519 . . . . 0.0 110.302 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 72' ' ' PHE . 69.4 m-85 -96.17 -44.05 7.46 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -170.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 64' ' ' GLU . 35.5 m -63.33 -37.49 31.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -172.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 4.8 Cg_exo -79.43 -8.42 14.98 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 121.604 1.536 . . . . 0.0 111.804 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.4 -7.04 39.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.126 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.45 12.24 29.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.983 177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 98.8 m-85 -100.37 120.78 40.48 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.701 -0.294 . . . . 0.0 110.516 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -93.16 98.48 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.062 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' B' ' 43' ' ' LYS . 20.8 m -64.0 142.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -120.82 -54.12 2.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.95 0.405 . . . . 0.0 110.488 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -138.36 -179.34 5.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.053 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG11 ' H ' ' B' ' 60' ' ' MET . 11.0 p -154.74 148.97 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 110.487 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -120.87 92.78 48.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.68 127.48 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.522 2.148 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.2 m -116.28 90.75 3.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.106 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.33 -28.36 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.232 0.539 . . . . 0.0 109.979 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.93 85.56 59.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.662 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.25 119.03 6.01 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.977 2.452 . . . . 0.0 112.32 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.725 179.055 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.67 0 N-CA-C 110.338 -0.678 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.4 -91.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.068 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 mm -119.78 99.98 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.524 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 1.6 pp -162.64 176.4 10.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.404 0.621 . . . . 0.0 112.506 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 127.59 36.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.924 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.81 -23.73 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.512 0.507 . . . . 0.0 111.582 -174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' B' ' 50' ' ' PRO . 12.7 pt -141.48 167.11 16.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.995 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 12.2 t -97.09 140.28 31.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.441 0.638 . . . . 0.0 110.122 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . 153.87 -156.27 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.839 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.81 107.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 2.6 p -82.42 125.77 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.988 0.423 . . . . 0.0 110.104 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -127.04 166.53 17.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' B' ' 45' ' ' ARG . 28.7 m-85 -123.0 130.33 52.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.409 ' C ' ' HB3' ' B' ' 45' ' ' ARG . . . -104.05 -172.49 25.31 Favored Glycine 0 C--O 1.239 0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.271 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 132.69 47.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.711 0.767 . . . . 0.0 112.182 -175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.01 163.75 25.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.327 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -149.41 140.26 22.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 111.215 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 56.07 65.07 1.53 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.136 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.46 63.38 4.53 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.655 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -148.5 -179.47 6.99 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -158.69 125.29 4.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.705 ' NH1' ' HG ' ' A' ' 60' ' ' LEU . 40.2 ttm-85 -82.47 100.76 10.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.122 -176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' B' ' 61' ' ' ILE . 16.5 tp -78.44 105.4 9.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.334 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -123.77 103.48 12.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.315 0.578 . . . . 0.0 110.015 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 28.8 mt -90.23 138.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA3' ' B' ' 32' ' ' GLY . 90.0 m -102.43 95.17 5.65 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.22 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 31' ' ' SER . 25.3 Cg_endo -62.99 130.94 30.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.909 2.406 . . . . 0.0 112.595 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.533 HG21 ' CZ ' ' B' ' 74' ' ' ARG . 27.0 m -111.3 -24.48 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.699 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.68 -22.3 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.659 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.49 -171.52 39.52 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.7 m -94.53 67.84 3.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.216 0.531 . . . . 0.0 110.535 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' O ' HD13 ' B' ' 30' ' ' ILE . 8.7 m-20 -118.19 84.62 22.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.614 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.41 126.99 16.5 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.199 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.465 ' HA ' HD22 ' A' ' 56' ' ' LEU . 77.6 t80 -134.85 111.17 9.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.334 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -124.74 147.25 48.75 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.709 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -153.33 145.2 23.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.014 0.435 . . . . 0.0 110.804 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.505 ' H ' HG11 ' A' ' 77' ' ' VAL . 39.2 ttp -79.88 81.52 6.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' B' ' 46' ' ' LEU . 15.2 tt -85.61 127.83 61.44 Favored Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.247 -174.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 61' ' ' ILE . 7.1 Cg_exo -73.84 143.93 34.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.048 1.832 . . . . 0.0 112.233 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' B' ' 63' ' ' LYS . 1.5 tmmm? -71.6 -22.73 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.69 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -0.43 54.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.881 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.439 ' HD2' HG13 ' B' ' 61' ' ' ILE . 36.3 ttm180 -86.48 156.04 20.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.42 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' B' ' 66' ' ' GLN . 3.5 pm0 -68.05 99.52 0.88 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.584 0.707 . . . . 0.0 109.378 171.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.403 HD23 HD13 ' B' ' 61' ' ' ILE . 7.5 mt -78.26 157.27 29.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.074 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.31 -54.04 7.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.716 HG22 ' H ' ' B' ' 70' ' ' PHE . 9.3 p -167.79 -176.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.716 ' H ' HG22 ' B' ' 69' ' ' VAL . 87.7 m-85 -77.26 173.1 12.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 110.709 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 12.4 pt-20 -80.65 146.7 31.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.019 0.438 . . . . 0.0 111.241 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.35 22.28 77.74 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.292 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.533 ' CZ ' HG21 ' B' ' 51' ' ' VAL . 9.7 tpt180 -91.91 119.93 32.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.631 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 m -133.0 161.32 41.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.656 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 33.1 tt0 -112.77 151.29 30.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -55.46 118.3 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.96 0.41 . . . . 0.0 111.694 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' B' ' 27' ' ' LEU . . . 96.9 -39.13 2.87 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.479 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -92.08 118.54 30.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.112 0.456 . . . . 0.0 111.41 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.5 p -176.55 -52.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 mm -117.96 -51.85 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.313 0.577 . . . . 0.0 110.569 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 9.0 t -163.25 111.44 1.24 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.22 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.68 148.48 22.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.743 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.239 -1.311 . . . . 0.0 111.063 179.5 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 11.4 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 120.95 0.405 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 66' ' ' GLN . . . -84.88 57.53 5.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.896 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -104.7 168.99 8.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.793 0.33 . . . . 0.0 110.591 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 52' ' ' TYR . 50.1 mt -84.82 -168.5 2.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.008 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -173.97 -163.56 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 33' ' ' ASN . 12.5 p -60.72 140.68 18.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -111.67 35.29 3.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.043 0.449 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.74 -27.48 68.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.12 0.486 . . . . 0.0 111.755 -178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.745 ' N ' HD22 ' A' ' 33' ' ' ASN . 9.6 mmpt? -121.8 -179.47 4.13 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.424 176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE2' ' SG ' ' A' ' 80' ' ' CYS . 24.4 pttm -137.4 117.32 13.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.538 0.685 . . . . 0.0 110.77 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 12.0 m-85 -124.9 117.29 23.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -97.68 103.72 15.68 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.334 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.5 122.46 39.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.043 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -90.85 111.82 23.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.631 0.729 . . . . 0.0 109.146 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 72' ' ' PHE . 1.4 t -106.53 136.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.048 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -112.28 119.79 39.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.625 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 p -84.52 -166.24 1.4 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 m -77.54 -1.68 31.83 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.911 0.386 . . . . 0.0 110.549 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.02 -61.52 0.98 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.93 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -125.84 136.92 53.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.719 -168.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 18.9 p -98.05 140.69 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.96 174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -143.04 155.82 44.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.1 118.69 35.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.173 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 p -126.78 134.23 25.86 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.782 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 23.5 Cg_exo -65.43 148.18 87.73 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.317 2.011 . . . . 0.0 112.168 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.5 mm -104.51 130.9 54.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 29' ' ' LEU . 29.2 m-85 -106.09 110.1 22.25 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.732 -172.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . . . -155.62 171.15 20.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.537 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -86.51 -42.45 13.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.566 0.222 . . . . 0.0 111.046 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 m -124.15 153.22 41.84 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.173 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.63 -49.27 57.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -47.62 -48.03 28.64 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.576 0.547 . . . . 0.0 112.203 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 27.1 tp10 -67.62 -44.35 78.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . . . -59.93 -41.66 92.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.05 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' B' ' 58' ' ' GLU . 17.3 tp -59.88 -37.23 78.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.825 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -74.93 -45.78 40.19 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.933 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 58' ' ' GLU . 81.6 mt -63.79 -38.79 92.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.833 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.39 -44.59 45.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.081 0.467 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.4 tt0 -81.29 -65.1 1.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.721 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -30.36 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' THR . 30.2 tt0 -84.52 -32.61 23.81 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 111.32 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -97.13 -35.2 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 72' ' ' PHE . 30.0 m -63.03 -36.51 25.35 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' ' CG2' ' A' ' 68' ' ' VAL . 5.1 Cg_exo -75.87 -7.51 18.42 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 121.587 1.525 . . . . 0.0 112.296 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.69 5.42 51.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.027 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.31 24.41 31.48 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.413 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.6 m-85 -122.05 148.14 45.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -120.75 127.93 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.54 130.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' HE2' ' B' ' 43' ' ' LYS . 27.6 m -98.19 -48.04 5.24 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.534 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -159.77 164.1 34.07 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.13 151.48 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -130.68 91.05 38.55 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.724 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.39 128.44 4.12 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.077 2.518 . . . . 0.0 111.623 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.46 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 66.7 m -81.1 89.14 5.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.215 0.531 . . . . 0.0 109.996 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.73 -44.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.273 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 74.87 79.53 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.64 -1.7 11.09 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.747 2.298 . . . . 0.0 113.414 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.072 -179.356 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.475 0.439 0 N-CA-C 110.286 -0.698 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 -141.49 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' B' ' 66' ' ' GLN . 17.8 mm -79.77 75.19 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.347 0.594 . . . . 0.0 109.428 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' CG1' ' B' ' 80' ' ' VAL . 3.4 pp -148.39 164.58 33.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.658 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.78 132.84 35.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.563 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' ARG . 8.2 tp10 -64.87 -25.38 67.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.947 -176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.56 171.07 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.833 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' B' ' 76' ' ' GLU . 23.0 t -92.72 151.21 20.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.35 -160.06 27.57 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.195 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' B' ' 74' ' ' ARG . 32.2 mm -95.94 107.45 19.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 48' ' ' ILE . 7.7 p -76.22 131.25 35.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' B' ' 71' ' ' GLU . 15.4 p -135.61 161.18 36.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.646 ' CD2' ' HB3' ' B' ' 71' ' ' GLU . 32.0 m-85 -120.64 133.2 55.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.959 0.409 . . . . 0.0 110.361 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' B' ' 45' ' ' ARG . . . -106.52 -154.31 20.41 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.65 138.59 34.39 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.483 0.659 . . . . 0.0 111.557 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.661 ' HB3' ' O ' ' B' ' 43' ' ' LYS . 16.7 mt-10 -114.87 126.07 54.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.234 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -56.78 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.07 0.462 . . . . 0.0 110.584 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -141.71 -65.56 0.42 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.25 17.41 44.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 171.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' B' ' 39' ' ' GLU . 5.3 tptp -102.04 177.61 4.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.236 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' B' ' 39' ' ' GLU . 32.0 ttm180 -160.64 133.05 6.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 36' ' ' PHE . 72.8 ttt180 -78.26 105.98 9.87 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.355 -0.538 . . . . 0.0 110.435 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.418 ' HG ' HG13 ' B' ' 61' ' ' ILE . 2.5 tm? -85.1 109.07 17.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.9 106.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.221 0.534 . . . . 0.0 110.673 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' B' ' 34' ' ' VAL . 41.6 mt -88.37 137.65 20.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 27.7 m -104.85 93.09 5.81 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.509 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.57 129.47 26.6 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.749 2.299 . . . . 0.0 112.23 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.42 -16.72 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.658 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -108.97 27.42 9.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.159 0.504 . . . . 0.0 110.414 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.17 171.47 30.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.624 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' B' ' 56' ' ' PRO . 49.1 m -105.28 47.25 0.88 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.932 0.396 . . . . 0.0 110.515 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -104.8 90.49 3.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.971 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' B' ' 54' ' ' SER . 14.7 Cg_exo -71.81 150.55 56.01 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.613 2.208 . . . . 0.0 111.907 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -151.43 110.43 3.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 109.814 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.443 ' HB3' HD22 ' A' ' 60' ' ' LEU . 28.5 mp0 -127.93 138.11 52.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.644 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -148.96 161.5 41.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.012 0.434 . . . . 0.0 110.866 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.428 ' HE2' ' HB2' ' B' ' 60' ' ' MET . 12.6 tpp -96.56 79.21 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.183 0.516 . . . . 0.0 109.917 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ILE . . . . . 0.418 HG13 ' HG ' ' B' ' 46' ' ' LEU . 20.5 mm -82.77 132.87 50.21 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.384 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 43' ' ' LYS . 72.7 Cg_endo -77.99 151.99 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.783 1.656 . . . . 0.0 111.751 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -10.29 59.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.253 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' TRP . . . . . 0.445 ' CD2' ' HB2' ' B' ' 62' ' ' PRO . 0.0 OUTLIER -87.61 -8.06 56.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.97 176.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 62' ' ' PRO . 19.6 tpp180 -79.11 135.84 36.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.491 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.43 ' HB3' HD12 ' B' ' 26' ' ' ILE . 7.7 tt0 -69.83 108.22 3.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 54.6 mt -78.36 161.95 26.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.229 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.411 ' HB2' HG11 ' B' ' 80' ' ' VAL . 18.8 p-10 -73.91 -41.46 62.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.281 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 70' ' ' PHE . 7.4 p -169.87 -176.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.729 ' H ' HG22 ' B' ' 69' ' ' VAL . 48.0 m-85 -77.06 173.14 12.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.738 0.304 . . . . 0.0 110.206 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.646 ' HB3' ' CD2' ' B' ' 36' ' ' PHE . 14.8 pt-20 -80.91 149.01 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.0 111.381 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.95 19.01 75.97 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -108.4 144.9 35.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.995 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.408 ' HA ' HD13 ' B' ' 33' ' ' ILE . 9.2 tpt180 -88.47 127.14 35.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.997 0.427 . . . . 0.0 111.047 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.79 176.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.968 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' OG ' ' B' ' 31' ' ' SER . 32.0 tt0 -126.99 163.55 23.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' B' ' 29' ' ' GLU . 50.3 ttp180 -62.11 113.16 2.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.62 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.66 -34.51 3.32 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 115.751 -0.658 . . . . 0.0 113.467 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.14 113.03 25.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.101 0.451 . . . . 0.0 111.874 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 27' ' ' LEU . 7.4 p -173.09 -63.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.872 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ILE . . . . . 0.516 ' H ' HG13 ' B' ' 80' ' ' VAL . 46.3 mm -120.82 -51.39 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.897 -0.502 . . . . 0.0 111.747 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -160.06 131.82 6.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.973 0.416 . . . . 0.0 110.503 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.29 143.44 27.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.452 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 CA-C-O 118.865 -0.964 . . . . 0.0 112.108 178.404 . . . . . . . . 0 0 . 1 stop_ save_